Ralph Weichselbaum

Ralph Weichselbaum's AcademicInfluence.com Rankings

Ralph Weichselbaum

Philosophy

#2721

World Rank

#4564

Historical Rank

#940

USA Rank

Logic

#745

World Rank

#1268

Historical Rank

#263

USA Rank

philosophy Degrees

Download Badge

Philosophy

Ralph Weichselbaum's Degrees

Doctorate Medicine University of Chicago
PhD Biochemistry University of Chicago

Why Is Ralph Weichselbaum Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Ralph R. Weichselbaum is an American physician specializing in radiation oncology, a member of the Institute of Medicine of the National Academy of Sciences, Ludwig professor, He is Daniel K. Ludwig Distinguished Service Professor of Radiation Oncology and Chairman, Department of Radiation and Cellular Oncology, at the University of Chicago Pritzker School of Medicine, and Head of the University of Chicago Center for Radiation Therapy, and the director of the Chicago Tumor Institute. Weichselbaum is also Co- Director of the Ludwig Center for Metastasis Research at the University of Chicago.

(See a Problem?)

Ralph Weichselbaum's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice. (2014) (1487)
Head and Neck Cancer (1993) (1386)
Accurate Three‐Dimensional Registration of CT, PET, and/or MR Images of the Brain (1989) (1263)
STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors. (2014) (1242)
Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment. (2009) (1134)
Blockade of the Vascular Endothelial Growth Factor Stress Response Increases the Antitumor Effects of Ionizing Radiation (1999) (814)
Proteolytic activation of protein kinase C delta by an ICE‐like protease in apoptotic cells. (1995) (712)
Combined effects of angiostatin and ionizing radiation in antitumour therapy (1998) (710)
Speech and survival: tradeoffs between quality and quantity of life in laryngeal cancer. (1981) (678)
Radiotherapy and immunotherapy: a beneficial liaison? (2017) (657)
The efficacy of radiotherapy relies upon induction of type i interferon-dependent innate and adaptive immunity. (2011) (641)
Oligometastases revisited (2011) (627)
p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage (1999) (623)
The Breast Cancer Susceptibility Gene BRCA1 Is Required for Subnuclear Assembly of Rad51 and Survival following Treatment with the DNA Cross-linking Agent Cisplatin* (2000) (611)
Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy (2016) (523)
Activation of the c-Abl tyrosine kinase in the stress response to DMA-damaging agents (1995) (510)
Integrative and Comparative Genomic Analysis of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinomas (2014) (499)
Fallacy of the five-year survival in lung cancer. (1978) (489)
Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. (1999) (487)
Increased tumor necrosis factor alpha mRNA after cellular exposure to ionizing radiation. (1989) (472)
An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer (2008) (464)
Anti-angiogenic cues from vascular basement membrane collagen. (2000) (426)
Ionizing radiation induces expression and binding activity of the nuclear factor kappa B. (1991) (417)
Predictors of competing mortality in advanced head and neck cancer. (2010) (414)
Role for Bcl-xL as an inhibitor of cytosolic cytochrome C accumulation in DNA damage-induced apoptosis. (1997) (398)
Nanoscale Metal–Organic Frameworks for Therapeutic, Imaging, and Sensing Applications (2018) (389)
Induced sensitization of tumor stroma leads to eradication of established cancer by T cells (2007) (374)
Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors. (2018) (364)
Holland-Frei Cancer Medicine (2016) (361)
Chlorin-Based Nanoscale Metal-Organic Framework Systemically Rejects Colorectal Cancers via Synergistic Photodynamic Therapy and Checkpoint Blockade Immunotherapy. (2016) (358)
Concomitant chemoradiotherapy: rationale and clinical experience in patients with solid tumors. (1990) (351)
Low-dose X-ray radiotherapy–radiodynamic therapy via nanoscale metal–organic frameworks enhances checkpoint blockade immunotherapy (2018) (338)
Spatial and temporal control of gene therapy using ionizing radiation (1995) (325)
Hsp27 functions as a negative regulator of cytochrome c-dependent activation of procaspase-3 (2000) (322)
Photodynamic Therapy Mediated by Nontoxic Core-Shell Nanoparticles Synergizes with Immune Checkpoint Blockade To Elicit Antitumor Immunity and Antimetastatic Effect on Breast Cancer. (2016) (312)
Improved survival time trends for glioblastoma using the SEER 17 population-based registries (2012) (308)
Integrative Analysis of Head and Neck Cancer Identifies Two Biologically Distinct HPV and Three Non-HPV Subtypes (2014) (299)
Ionizing radiation regulates expression of the c-jun protooncogene. (1990) (295)
STAT1 is overexpressed in tumors selected for radioresistance and confers protection from radiation in transduced sensitive cells. (2004) (283)
Histone H2AX Phosphorylation as a Predictor of Radiosensitivity and Target for Radiotherapy* (2004) (279)
Protein kinase C mediates x-ray inducibility of nuclear signal transducers EGR1 and JUN. (1991) (266)
Functional interaction between DNA-PK and c-Abl in response to DNA damage (1997) (259)
Host STING-dependent MDSC mobilization drives extrinsic radiation resistance (2017) (251)
The oligometastatic state—separating truth from wishful thinking (2014) (250)
MicroRNA Expression Characterizes Oligometastasis(es) (2011) (243)
Stereotactic body radiotherapy for multisite extracranial oligometastases (2012) (242)
p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines. (1993) (242)
Role for c-Abl tyrosine kinase in growth arrest response to DNA damage (1996) (237)
Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer. (2003) (235)
Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer. (2000) (231)
An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous-cell carcinoma of the head and neck. (1987) (229)
Targeting the tumor microenvironment with interferon-β bridges innate and adaptive immune responses. (2014) (225)
Potentiation of the antitumor effect of ionizing radiation by brief concomitant exposures to angiostatin. (1998) (224)
Xrcc3 Is Required for Assembly of Rad51 Complexes in Vivo * (1998) (222)
Ionizing radiation activates transcription of the EGR1 gene via CArG elements. (1992) (216)
Occurrence of p53 gene deletions and human papilloma virus infection in human head and neck cancer. (1992) (214)
A phase 1 trial of oncolytic HSV-1, G207, given in combination with radiation for recurrent GBM demonstrates safety and radiographic responses. (2014) (211)
X-ray sensitivity of fifty-three human diploid fibroblast cell strains from patients with characterized genetic disorders. (1980) (207)
Effect of antisense c-raf-1 on tumorigenicity and radiation sensitivity of a human squamous carcinoma. (1989) (205)
Regulation of DNA damage-induced apoptosis by the c-Abl tyrosine kinase. (1997) (202)
Extracranial oligometastases: a subset of metastases curable with stereotactic radiotherapy. (2013) (196)
TNFerade biologic, an adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene: a phase I study in patients with solid tumors. (2004) (195)
Nanoscale metal-organic frameworks enhance radiotherapy to potentiate checkpoint blockade immunotherapy (2018) (191)
Radiation-resistant and repair-proficient human tumor cells may be associated with radiotherapy failure in head- and neck-cancer patients. (1986) (188)
New Paradigms and Future Challenges in Radiation Oncology: An Update of Biological Targets and Technology (2013) (187)
Tumour-endothelium interactions in co-culture: coordinated changes of gene expression profiles and phenotypic properties of endothelial cells (2003) (185)
Radiation induction of immediate early genes: effectors of the radiation-stress response. (1994) (184)
Reactive oxygen intermediates target CC(A/T)6GG sequences to mediate activation of the early growth response 1 transcription factor gene by ionizing radiation. (1993) (182)
Oligo- and Polymetastatic Progression in Lung Metastasis(es) Patients Is Associated with Specific MicroRNAs (2012) (181)
Determination of cell fate by c-Abl activation in the response to DNA damage (1998) (180)
Vascular Endothelial Growth Factor Enhances Endothelial Cell Survival and Tumor Radioresistance (2002) (179)
The role of cervical lymphadenectomy after aggressive concomitant chemoradiotherapy: the feasibility of selective neck dissection. (2000) (178)
Radioresistant tumor cells are present in head and neck carcinomas that recur after radiotherapy. (1988) (177)
Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis (2018) (175)
In vitro and in vivo activity of protein kinase C inhibitor chelerythrine chloride induces tumor cell toxicity and growth delay in vivo. (2000) (174)
Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation. (2005) (174)
p53 Expression Induces Apoptosis in Hippocampal Pyramidal Neuron Cultures (1997) (173)
Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival. (1996) (172)
Dendritic Cells but Not Macrophages Sense Tumor Mitochondrial DNA for Cross‐priming through Signal Regulatory Protein &agr; Signaling (2017) (171)
Limited penetration of methotrexate into human osteosarcoma spheroids as a proposed model for solid tumor resistance to adjuvant chemotherapy. (1980) (169)
Loss of ceramide production confers resistance to radiation-induced apoptosis. (1997) (168)
Tumour ischaemia by interferon-γ resembles physiological blood vessel regression (2017) (168)
Deficient recovery from potentially lethal radiation damage in ataxia telangiectasia and xeroderma pigmentosum (1978) (165)
Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer. (2001) (162)
The raf oncogene is associated with a radiation-resistant human laryngeal cancer. (1987) (162)
Involvement of reactive oxygen intermediates in the induction of c-jun gene transcription by ionizing radiation. (1992) (162)
Biological consequences of gene regulation after ionizing radiation exposure. (1991) (162)
Swallowing function in patients with head and neck cancer prior to treatment. (2000) (161)
Network Modeling Identifies Molecular Functions Targeted by miR-204 to Suppress Head and Neck Tumor Metastasis (2010) (159)
Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer. (1996) (159)
Statin use and risk of prostate cancer recurrence in men treated with radiation therapy. (2010) (157)
Gene therapy targeted by radiation preferentially radiosensitizes tumor cells. (1994) (155)
Suppression of Bcl-2 messenger RNA production may mediate apoptosis after ionizing radiation, tumor necrosis factor alpha, and ceramide. (1995) (155)
Immunostimulatory nanomedicines synergize with checkpoint blockade immunotherapy to eradicate colorectal tumors (2019) (153)
Phase I study of bevacizumab added to fluorouracil- and hydroxyurea-based concomitant chemoradiotherapy for poor-prognosis head and neck cancer. (2008) (151)
Characterization of the Theorectical Radiation Dose Enhancement from Nanoparticles (2007) (151)
Blockade of tumor necrosis factor alpha signaling in tumor-associated macrophages as a radiosensitizing strategy. (2010) (150)
Activation of protein kinase C δ by the c-Abl tyrosine kinase in response to ionizing radiation (1998) (146)
Tumor necrosis factor gene expression is mediated by protein kinase C following activation by ionizing radiation. (1991) (145)
Molecular Pathways: Interferon/Stat1 Pathway: Role in the Tumor Resistance to Genotoxic Stress and Aggressive Growth (2012) (145)
Regulation of tumor necrosis factor gene expression by ionizing radiation in human myeloid leukemia cells and peripheral blood monocytes. (1991) (144)
Faster repair of DNA double-strand breaks in radioresistant human tumor cells. (1988) (143)
Overexpression of Bcl-XL by cytotoxic drug exposure confers resistance to ionizing radiation-induced internucleosomal DNA fragmentation. (1995) (140)
Cancer therapies activate RIG-I-like receptor pathway through endogenous non-coding RNAs (2016) (140)
The intersection of radiotherapy and immunotherapy: Mechanisms and clinical implications (2016) (139)
Conservative surgery and adjuvant radiation therapy in the management of adult soft tissue sarcoma of the extremities: clinical and radiobiological results. (1995) (139)
Radiation-Induced Equilibrium Is a Balance between Tumor Cell Proliferation and T Cell–Mediated Killing (2013) (139)
STAT1-dependent expression of energy metabolic pathways links tumour growth and radioresistance to the Warburg effect (2009) (137)
Activation of a CrmA-insensitive, p35-sensitive Pathway in Ionizing Radiation-induced Apoptosis* (1997) (135)
Radiation as an immune modulator. (2013) (132)
Some retinoblastomas, osteosarcomas, and soft tissue sarcomas may share a common etiology. (1988) (130)
Re-irradiation with concomitant chemotherapy of unresectable recurrent head and neck cancer: a potentially curable disease. (1996) (130)
Gene therapy of cancer (1997) (128)
Proliferation Kinetics of a Human Breast Cancer Line in Vitro following Treatment with 17β-Estradiol and 1-β-d-Arabinofuranosylcytosine (1978) (125)
A chemical compound that stimulates the human homologous recombination protein RAD51 (2008) (123)
Radiation therapy in the management of patients with mesothelioma. (1980) (123)
Signal transducer and activator of transcription 1 regulates both cytotoxic and prosurvival functions in tumor cells. (2007) (121)
Tumor-reprogrammed resident T cells resist radiation to control tumors (2019) (121)
Hydroxyurea, fluorouracil, and concomitant radiotherapy in poor-prognosis head and neck cancer: a phase I-II study. (1989) (121)
c-jun and Egr-1 Participate in DNA Synthesis and Cell Survival in Response to Ionizing Radiation Exposure (*) (1995) (120)
Inherently radioresistant cells exist in some human tumors. (1985) (120)
STAT1 Pathway Mediates Amplification of Metastatic Potential and Resistance to Therapy (2009) (118)
Expression Signature of IFN/STAT1 Signaling Genes Predicts Poor Survival Outcome in Glioblastoma Multiforme in a Subtype-Specific Manner (2012) (116)
Non‐canonical NF‐&kgr;B Antagonizes STING Sensor‐Mediated DNA Sensing in Radiotherapy (2018) (116)
A rationale for the targeted treatment of oligometastases with radiotherapy (2008) (115)
Intratumoral accumulation of gut microbiota facilitates CD47-based immunotherapy via STING signaling (2020) (115)
Cellular repair factors influencing radiocurability of human malignant tumours. (1982) (114)
MUC1-induced alterations in a lipid metabolic gene network predict response of human breast cancers to tamoxifen treatment (2009) (113)
The repair of potentially lethal damage in x-irradiated cultures of normal and ataxia telangiectasia human fibroblasts. (1981) (111)
The interaction between recombinant human tumor necrosis factor and radiation in 13 human tumor cell lines. (1990) (111)
Sphingosine-1-phosphate, FTY720, and sphingosine-1-phosphate receptors in the pathobiology of acute lung injury. (2013) (109)
Decreasing the apoptotic threshold of tumor cells through protein kinase C inhibition and sphingomyelinase activation increases tumor killing by ionizing radiation. (1997) (109)
Induction chemotherapy followed by concurrent chemoradiation for advanced head and neck cancer: improved disease control and survival. (1998) (108)
Extraction and assembly of tissue-derived gels for cell culture and tissue engineering. (2009) (107)
MUC1-induced transcriptional programs associated with tumorigenesis predict outcome in breast and lung cancer. (2009) (107)
The Essential Functions of Human Rad51 Are Independent of ATP Hydrolysis (1999) (107)
Poly(ADP-ribose) polymerase inhibitor induces accelerated senescence in irradiated breast cancer cells and tumors. (2010) (106)
Analysis of further disease progression in metastatic non-small cell lung cancer: implications for locoregional treatment. (2004) (106)
Hypofractionated Image-Guided Radiation Therapy for Patients with Limited Volume Metastatic Non-small Cell Lung Cancer (2012) (106)
Tumor necrosis factor α (TNF-α) gene therapy targeted by ionizing radiation selectively damages tumor vasculature (1996) (105)
Activation of Src-like p56/p53lyn tyrosine kinase by ionizing radiation. (1994) (104)
Stereotactic Body Radiotherapy for the Treatment of Oligometastatic Renal Cell Carcinoma (2013) (104)
Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for locally advanced head and neck cancer: a clinical and pharmacologic analysis. (1990) (103)
DNA repair in a Fanconi's anemia fibroblast cell strain. (1979) (103)
Tumor-associated fibroblasts predominantly come from local and not circulating precursors (2016) (102)
14q32-encoded microRNAs mediate an oligometastatic phenotype (2015) (102)
Replication-competent, nonneuroinvasive genetically engineered herpes virus is highly effective in the treatment of therapy-resistant experimental human tumors. (1999) (102)
A Critical Role of the IL-1β-IL-1R Signaling Pathway in Skin Inflammation and Psoriasis Pathogenesis. (2019) (102)
Virally directed cytosine deaminase/5-fluorocytosine gene therapy enhances radiation response in human cancer xenografts. (1997) (102)
Late rectal sequelae following definitive radiation therapy for carcinoma of the uterine cervix: a dosimetric analysis. (1997) (101)
Clinical and molecular markers of long‐term survival after oligometastasis‐directed stereotactic body radiotherapy (SBRT) (2016) (101)
Radiation or surgery for chemodectoma of the temporal bone: A review of local control and complications (1990) (100)
Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma. (2002) (100)
Ionizing radiation induces rapid tyrosine phosphorylation of p34cdc2. (1994) (97)
Radiation therapy in the treatment of aggressive fibromatoses. (1981) (96)
Inhibition of protein kinases sensitizes human tumor cells to ionizing radiation. (1992) (96)
Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer. (1992) (96)
Palliation of hepatic metastasis (1978) (95)
The stress response to ionizing radiation involoves c-Abl-dependent phosphorylation of SHPTP1. (1996) (95)
Combined modality therapy of head and neck cancer. (1994) (94)
Increasing radiation therapy dose is associated with improved survival in patients undergoing stereotactic body radiation therapy for stage I non-small-cell lung cancer. (2015) (93)
Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal cancer. (2003) (93)
A Phase I Trial of TNFerade Biologic in Patients with Soft Tissue Sarcoma in the Extremities (2004) (93)
Radiobiological characterization of 53 human tumor cell lines. (1989) (92)
X-ray sensitivity of human tumor cells in vitro. (1980) (92)
MUC1-C ACTIVATES THE TAK1 INFLAMMATORY PATHWAY IN COLON CANCER (2015) (91)
Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells (2019) (90)
Incidence of hypothyroidism following multimodality treatment for advanced squamous cell cancer of the head and neck (1984) (89)
p53 gene mutations and abnormal retinoblastoma protein in radiation-induced human sarcomas. (1991) (89)
Epidermal growth factor receptor gene amplification and expression in head and neck cancer cell lines (1989) (88)
COOPERATIVITY OF THE MUC1 ONCOPROTEIN AND STAT1 PATHWAY IN POOR PROGNOSIS HUMAN BREAST CANCER (2009) (88)
Activated MEK Suppresses Activation of PKR and Enables Efficient Replication and In Vivo Oncolysis by Δγ134.5 Mutants of Herpes Simplex Virus 1 (2006) (88)
An Initial Report of a Radiation Dose-Escalation Trial in Patients with One to Five Sites of Metastatic Disease (2008) (88)
Oncogenic CXCL10 signalling drives metastasis development and poor clinical outcome (2015) (88)
Patterns of failure following high-dose chemotherapy and autologous bone marrow transplantation with involved field radiotherapy for relapsed/refractory Hodgkin's disease. (1995) (87)
Potency probability following conformal megavoltage radiotherapy using conventional doses for localized prostate cancer. (1997) (87)
Coinduction of c-jun gene expression and internucleosomal DNA fragmentation by ionizing radiation. (1993) (85)
Skin fibroblasts from a D-deletion type retinoblastoma patient are abnormally X-ray sensitive (1977) (85)
Prognostic Factors in Advanced Head and Neck Cancer Patients Undergoing Multimodality Therapy (1991) (84)
Classification for long-term survival in oligometastatic patients treated with ablative radiotherapy: A multi-institutional pooled analysis (2018) (84)
TNFerade Biologic: Preclinical toxicology of a novel adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene (2002) (84)
Radiation-induced tumour necrosis factor-alpha expression: clinical application of transcriptional and physical targeting of gene therapy. (2002) (83)
In vivo replication-deficient adenovirus vector-mediated transduction of the cytosine deaminase gene sensitizes glioma cells to 5-fluorocytosine. (1996) (83)
DNA Repair Pathway Gene Expression Score Correlates with Repair Proficiency and Tumor Sensitivity to Chemotherapy (2014) (83)
Surfactant Sealing of Membranes Permeabilized by Ionizing Radiation (2000) (82)
Defective induction of stress-activated protein kinase activity in ataxia-telangiectasia cells exposed to ionizing radiation. (1995) (82)
X-ray sensitivity of diploid fibroblasts from patients with hereditary or sporadic retinoblastoma. (1978) (81)
Protein kinase C inhibition induces apoptosis and ceramide production through activation of a neutral sphingomyelinase. (1996) (80)
gamma-H2AX as a therapeutic target for improving the efficacy of radiation therapy. (2006) (80)
Pilot study examining tumor expression of RAD51 and clinical outcomes in human head cancers. (2006) (80)
Convection-enhanced delivery and in vivo imaging of polymeric nanoparticles for the treatment of malignant glioma. (2014) (78)
Increased glutathione peroxidase activity in a human sarcoma cell line with inherent doxorubicin resistance. (1991) (78)
Genetically engineered HSV in the treatment of glioma: a review (2000) (78)
Cytogenetic evidence of the multistep origin of head and neck squamous cell carcinomas. (1992) (78)
Tumor necrosis factor-alpha-based gene therapy enhances radiation cytotoxicity in human prostate cancer. (1998) (78)
c-Abl Tyrosine Kinase Regulates Caspase-9 Autocleavage in the Apoptotic Response to DNA Damage* (2005) (77)
Ionizing Radiation Stimulates a Grb2-mediated Association of the Stress-activated Protein Kinase with Phosphatidylinositol 3-Kinase (*) (1995) (76)
Improved Survival Associated with Neoadjuvant Chemoradiation in Patients with Clinical Stage IIIA(N2) Non–Small-Cell Lung Cancer (2013) (76)
Integration of radiotherapy and immunotherapy for treatment of oligometastases. (2019) (75)
Multimodality therapy in advanced paranasal sinus carcinoma: superior long-term results. (1999) (75)
Thymidylate synthase expression and response to neoadjuvant chemotherapy in patients with advanced head and neck cancer. (1997) (74)
Induction chemotherapy followed by concomitant TFHX chemoradiotherapy with reduced dose radiation in advanced head and neck cancer. (2003) (72)
Towards a molecular basis of oligometastatic disease: potential role of micro-RNAs (2014) (71)
cis-Diamminedichloroplatinum(II) induces c-jun expression in human myeloid leukemia cells: potential involvement of a protein kinase C-dependent signaling pathway. (1992) (71)
Cisplatin, fluorouracil, and high-dose leucovorin for recurrent or metastatic head and neck cancer. (1988) (71)
Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, and hydroxyurea with granulocyte colony-stimulating factor support for patients with poor-prognosis cancer of the head and neck. (1998) (71)
Multicenter randomized Phase II study of paclitaxel (1-hour infusion), fluorouracil, hydroxyurea, and concomitant twice daily radiation with or without erythropoietin for advanced head and neck cancer. (2003) (71)
Loss of Nfkb1 leads to early onset aging (2014) (70)
Response of Human Prostate Cancer Cells and Tumors to Combining PARP Inhibition with Ionizing Radiation (2011) (70)
CD95/Fas Increases Stemness in Cancer Cells by Inducing a STAT1-Dependent Type I Interferon Response. (2017) (70)
Treatment of advanced squamous cell carcinoma of the head and neck with cisplatin, bleomycin, and methotrexate (PBM). (1981) (70)
An analysis of radiation necrosis of the central nervous system treated with bevacizumab (2014) (70)
Intensified concomitant chemoradiotherapy with and without filgrastim for poor-prognosis head and neck cancer. (1994) (69)
Cisplatin, fluorouracil, and leucovorin augmented by interferon alfa-2b in head and neck cancer: a clinical and pharmacologic analysis. (1993) (69)
Dose-dependent and independent temporal patterns of gene responses to ionizing radiation in normal and tumor cells and tumor xenografts (2001) (68)
Radiation-inducible immunotherapy for cancer: senescent tumor cells as a cancer vaccine. (2012) (67)
Activated MEK suppresses activation of PKR and enables efficient replication and in vivo oncolysis by Deltagamma(1)34.5 mutants of herpes simplex virus 1. (2006) (67)
Function for p300 and not CBP in the apoptotic response to DNA damage (1999) (67)
Race and clinical outcome in breast cancer in a series with long-term follow-up evaluation. (1997) (65)
Radiobiological characterization of head and neck and sarcoma cells derived from patients prior to radiotherapy. (1990) (64)
Radiation Therapy—Activation of Gene Transcription and the Development of Genetic Radiotherapy: Therapeutic Strategies in Oncology (2003) (64)
Temozolomide Treatment Induces lncRNA MALAT1 in an NF-κB and p53 Codependent Manner in Glioblastoma. (2019) (63)
The treatment of stage III nonsmall cell lung cancer using high dose conformal radiotherapy. (1995) (63)
From DNA Damage to Nucleic Acid Sensing: A Strategy to Enhance Radiation Therapy (2015) (63)
Nuclear signaling induced by ionizing radiation involves colocalization of the activated p56/p53lyn tyrosine kinase with p34cdc2. (1996) (63)
Human Organoids Share Structural and Genetic Features with Primary Pancreatic Adenocarcinoma Tumors (2018) (63)
Poloxamer 188 prevents acute necrosis of adult skeletal muscle cells following high-dose irradiation. (2004) (63)
Radiation-induced DNA double-strand break frequencies in human squamous cell carcinoma cell lines of different radiation sensitivities. (1991) (63)
Two prostate carcinoma cell lines demonstrate abnormalities in tumor suppressor genes (1991) (63)
MUC1-associated proliferation signature predicts outcomes in lung adenocarcinoma patients (2010) (62)
Down-regulation of cell cycle control genes by ionizing radiation. (1992) (61)
The confluence of radiotherapy and immunotherapy (2012) (61)
Changing face and different countenances of prostate cancer: Racial and geographic differences in prostate‐specific antigen (PSA), stage, and grade trends in the PSA era (2001) (61)
RIG-I–like receptor LGP2 protects tumor cells from ionizing radiation (2014) (61)
Fecal microbiota transplant rescues mice from human pathogen mediated sepsis by restoring systemic immunity (2020) (61)
Two prostate carcinoma cell lines demonstrate abnormalities in tumor suppressor genes. (1991) (61)
Eradication of Large Solid Tumors by Gene Therapy with a T-Cell Receptor Targeting a Single Cancer-Specific Point Mutation (2015) (60)
Genetic radiotherapy overcomes tumor resistance to cytotoxic agents. (1995) (60)
Functional imaging in treatment planning of brain lesions. (1997) (60)
Oligometastatic prostate cancer: Reality or figment of imagination? (2018) (60)
In vitro radiosensitivity of human dipliod fibroblasts derived from patients with unusual clinical responses to radiation. (1976) (60)
Radiotherapy and Immunotherapy for Cancer: From “Systemic” to “Multisite” (2020) (59)
Breast preservation in stage I and II carcinoma of the breast: The University of Chicago experience (1996) (59)
Simvastatin attenuates radiation-induced murine lung injury and dysregulated lung gene expression. (2011) (58)
Role of sphingolipids in murine radiation‐induced lung injury: protection by sphingosine 1‐phosphate analogs (2011) (58)
Radiotherapy of the resected mandible following stainless steel plate fixation (1988) (58)
Magnetic resonance imaging identifies multifocal and multicentric disease in breast cancer patients who are eligible for partial breast irradiation (2008) (58)
Heterogeneity of radiation response of a parent human epidermoid carcinoma cell line and four clones. (1988) (58)
Radioresistance of Stat1 over-expressing tumour cells is associated with suppressed apoptotic response to cytotoxic agents and increased IL6-IL8 signalling (2009) (58)
Radiation signaling mediated by Jun activation following dissociation from a cell type-specific repressor. (1993) (58)
Combination of radiotherapy and vaccination overcomes checkpoint blockade resistance (2016) (57)
Phase I dose-escalation study of tumor necrosis factor-alpha and concomitant radiation therapy. (1995) (57)
Nasopharyngeal carcinoma (1997) (57)
Differentiation and retrodifferentiation of human myeloid leukemia cells is associated with reversible induction of cell cycle-regulatory genes. (1992) (57)
Glioblastoma cells block radiation‐induced programmed cell death of endothelial cells (2004) (57)
Herpes simplex virus 1 activates cdc2 to recruit topoisomerase IIα for post-DNA synthesis expression of late genes (2003) (57)
Human papillomavirus expression and p53 gene mutations in squamous cell carcinoma. (1997) (56)
In vitro cellular radiosensitivity of human malignant tumors. (1976) (56)
Response of human osteosarcoma in vitro to irradiation: evidence for unusual cellular repair activity. (1977) (56)
Locoregionally advanced paranasal sinus carcinoma. Favorable survival with multimodality therapy. (1993) (56)
Stereotactic Body Radiation Therapy for Curative Treatment of Adrenal Metastases (2013) (55)
Pharmacodynamics of fluorouracil-based induction chemotherapy in advanced head and neck cancer. (1996) (55)
Efficacy and safety of treating T4 oral cavity tumors with primary chemoradiotherapy (2009) (55)
Speech and survival. (2010) (55)
Activation of the pp90rsk and mitogen-activated serine/threonine protein kinases by ionizing radiation. (1994) (55)
Ultrathin metal-organic layer-mediated radiotherapy-radiodynamic therapy enhances immunotherapy of metastatic cancers. (2019) (54)
The role of cytokines in radiation oncology. (1993) (54)
RAD54 family translocases counter genotoxic effects of RAD51 in human tumor cells (2015) (54)
Interaction of amifostine and ionizing radiation on transcriptional patterns of apoptotic genes expressed in human microvascular endothelial cells (HMEC). (2004) (54)
Prophylactic cranial irradiation in adenocarcinoma of the lung a possible role (1987) (53)
Functional role for the c-Abl tyrosine kinase in meiosis I (1998) (53)
In vitro radiosensitivity of human leukemia cell lines. (1981) (52)
Cisplatin and fluorouracil chemotherapy does not yield long-term benefit in locally advanced head and neck cancer: results from a single institution. (1991) (52)
Enhanced eradication of local and distant tumors by genetically produced interleukin-12 and radiation. (1999) (52)
Ionizing radiation activates late herpes simplex virus 1 promoters via the p38 pathway in tumors treated with oncolytic viruses. (2005) (52)
Variation in radiation sensitivity during the cell cycle of two human squamous cell carcinomas. (1991) (51)
Defining the Benefit of Adjuvant Therapy Following Resection for Intrahepatic Cholangiocarcinoma (2015) (51)
The maximum recovery potential of human tumor cells may predict clinical outcome in radiotherapy. (1987) (51)
Posttranslational Processing of Infected Cell Proteins 0 and 4 of Herpes Simplex Virus 1 Is Sequential and Reflects the Subcellular Compartment in Which the Proteins Localize (2001) (50)
Recovery from sublethal and potentially lethal damage in an X-ray-sensitive CHO cell. (1987) (50)
An aggressive approach to marginally resectable lung cancer (1978) (50)
Cyclopamine increases the cytotoxic effects of paclitaxel and radiation but not cisplatin and gemcitabine in Hedgehog expressing pancreatic cancer cells (2006) (50)
EPR oxygen images predict tumor control by a 50% tumor control radiation dose. (2013) (50)
Treatment complications after sequential combination chemotherapy and radiotherapy with or without surgery in previously untreated squamous cell carcinoma of the head and neck. (1985) (49)
Chemotherapy of advanced salivary gland neoplasms (1982) (49)
Lack of supporting data make the risks of a clinical trial of radiation therapy as a treatment for COVID-19 pneumonia unacceptable☆ (2020) (49)
Cholesterol metabolism and resistance to tamoxifen. (2012) (49)
Abnormal sensitivity of diploid skin fibroblasts from a family with gardner's syndrome to the lethal effects of X-irradiation, ultraviolet light and mitomycin-C. (1980) (48)
Tumor necrosis factor alpha (TNF-alpha) gene therapy targeted by ionizing radiation selectively damages tumor vasculature. (1996) (48)
Transcriptional Targeting of Adenovirally Delivered Tumor Necrosis Factor α by Temozolomide in Experimental Glioblastoma (2004) (48)
The 46th David A. Karnofsky Memorial Award Lecture: Oligometastasis-From Conception to Treatment. (2018) (48)
Gene therapy targeted by ionizing radiation. (1992) (48)
Temporal bone chemodectomas--comparing surgery and radiation therapy. (1991) (48)
The relationship between expression of PD-L1 and HIF-1α in glioma cells under hypoxia (2021) (47)
NM-3, an isocoumarin, increases the antitumor effects of radiotherapy without toxicity. (2000) (47)
Prediction of the radiation sensitivity of human squamous cell carcinoma cells using DNA filter elution. (1990) (47)
The differential response of human tumours to fractionated radiation may be due to a post-irradiation repair process. (1982) (47)
ReVOLT: radiation-enhanced viral oncolytic therapy. (2006) (47)
Oxygen-Guided Radiation Therapy. (2019) (47)
Lactobacillus rhamnosus GG induces cGAS/STING- dependent type I interferon and improves response to immune checkpoint blockade (2021) (47)
Dual blockade of CD47 and HER2 eliminates radioresistant breast cancer cells (2020) (46)
Transcriptional control of viral gene therapy by cisplatin. (2002) (46)
A randomized study of inpatient versus outpatient continuous infusion chemotherapy for patients with locally advanced head and neck cancer (1989) (46)
Potency preservation following conformal radiotherapy for localized prostate cancer: impact of neoadjuvant androgen blockade, treatment technique, and patient-related factors. (1999) (46)
cdc2 Cyclin-Dependent Kinase Binds and Phosphorylates Herpes Simplex Virus 1 UL42 DNA Synthesis Processivity Factor (2001) (45)
Differences in Survival With Surgery and Postoperative Radiotherapy Compared With Definitive Chemoradiotherapy for Oral Cavity Cancer: A National Cancer Database Analysis (2017) (45)
Iodine-125-labelled tamoxifen is differentially cytoxic to cells containing oestrogen receptors. (1980) (44)
BCL3 expression promotes resistance to alkylating chemotherapy in gliomas (2018) (44)
Twice-daily reirradiation for recurrent and second primary head-and-neck cancer with gemcitabine, paclitaxel, and 5-fluorouracil chemotherapy. (2005) (44)
Integrated molecular and clinical staging defines the spectrum of metastatic cancer (2019) (44)
Antitumor interaction of short-course endostatin and ionizing radiation. (2000) (43)
p50 (NF-κB1) is an effector protein in the cytotoxic response to DNA methylation damage. (2011) (43)
Linking Cancer Metabolism to DNA Repair and Accelerated Senescence (2015) (43)
The transfacial approach for combined anterior craniofacial tumor ablation. (1989) (43)
The RAD51-stimulatory compound RS-1 can exploit the RAD51 overexpression that exists in cancer cells and tumors. (2014) (42)
Inhibition of serine palmitoyltransferase delays the onset of radiation-induced pulmonary fibrosis through the negative regulation of sphingosine kinase-1 expression[S] (2012) (42)
Extended mantle radiation therapy for pathologic stage I and II Hodgkin's disease. (1987) (42)
Predictors of competing mortality in early breast cancer (2010) (42)
Comparison of 3D Confromal Radiotherapy and Intensity Modulated Radiotherapy with or without Simultaneous Integrated Boost during Concurrent Chemoradiation for Locally Advanced Head and Neck Cancers (2014) (42)
Neoadjuvant vindesine, etoposide, and cisplatin for locally advanced non-small cell lung cancer. Final report of a phase 2 study. (1989) (42)
The characteristics of long‐term survivors of lung cancer treated with radiation (1981) (41)
Lethal effects of 1-beta-D-arabinofuranosylcytosine incorporation into deoxyribonucleic acid during ultraviolet repair. (1984) (41)
A survivin-associated adaptive response in radiation therapy. (2013) (41)
In Vivo Delivery and Therapeutic Effects of a MicroRNA on Colorectal Liver Metastases. (2017) (41)
STING Promotes Homeostasis via Regulation of Cell Proliferation and Chromosomal Stability. (2018) (41)
Angiostatin effects on endothelial cells mediated by ceramide and RhoA (2001) (40)
Role of migratory inhibition factor in age-related susceptibility to radiation lung injury via NF-E2-related factor-2 and antioxidant regulation. (2013) (40)
X-ray and cis-diamminedichloroplatinum(II) cross-resistance in human tumor cell lines. (1988) (40)
Mechanisms of X-ray-mediated protooncogene c-jun expression in radiation-induced human sarcoma cell lines. (1991) (39)
Sensitivities of NIH/3T3-derived clonal cell lines to ionizing radiation: significance for gene transfer studies. (1989) (39)
Activation of protein kinase C delta by the c-Abl tyrosine kinase in response to ionizing radiation. (1998) (39)
Western Diet Promotes Intestinal Colonization by Collagenolytic Microbes and Promotes Tumor Formation Following Colorectal Surgery. (2020) (39)
Inhibition of nuclear factor-kappaB activity by temozolomide involves O6-methylguanine induced inhibition of p65 DNA binding. (2007) (38)
Preoperative radiotherapy followed by radical vulvectomy with inguinal lymphadenectomy for advanced vulvar carcinomas. (1990) (38)
Combination of linear accelerator-based intensity-modulated total marrow irradiation and myeloablative fludarabine/busulfan: a phase I study. (2014) (38)
Cellular X-ray repair parameters of early passage squamous cell carcinoma lines derived from patients with known responses to radiotherapy. (1984) (38)
Importance of local control in an era of systemic therapy (2005) (38)
Translation of the radio- and chemo-inducible TNFerade vector to the treatment of human cancers (2009) (38)
Caution in interpreting biochemical control rates after treatment of prostate cancer: length of follow-up influences results. (1999) (38)
Tumor Endothelial Inflammation Predicts Clinical Outcome in Diverse Human Cancers (2012) (38)
Radioresistant and repair proficient cells may determine radiocurability in human tumors. (1986) (38)
Low-Dose Radiation Therapy (LDRT) for COVID-19: Benefits or Risks? (2020) (38)
Ionizing radiation: a genetic switch for cancer therapy (2006) (37)
p56/p53lyn tyrosine kinase activation in mammalian cells treated with mitomycin C. (1994) (37)
Promoting the Appropriate Use of Advanced Radiation Technologies in Oncology: Summary of a National Cancer Policy Forum Workshop. (2017) (36)
E2F Proteins Are Posttranslationally Modified Concomitantly with a Reduction in Nuclear Binding Activity in Cells Infected with Herpes Simplex Virus 1 (2000) (36)
The role of radiotherapy in locally advanced pancreatic carcinoma (2010) (36)
Down-regulation of ceramide production abrogates ionizing radiation-induced cytochrome c release and apoptosis. (2000) (36)
Prognostic factors in patients with subdiaphragmatic Hodgkin's disease (2007) (36)
Poloxamine 1107 sealing of radiopermeabilized erythrocyte membranes. (1999) (35)
Increased therapeutic index using moderate dose methotrexate and leucovorin twice weekly vs. weekly high dose methotrexate‐leucovorin in patients with advanced squamous carcinoma of the head and neck: A safe new effective regimen (1981) (35)
Cooperative Interaction between the MUC1-C Oncoprotein and the Rab31 GTPase in Estrogen Receptor-Positive Breast Cancer Cells (2012) (35)
Molecular targeting of gene therapy and radiotherapy. (2001) (34)
Local gene delivery of tumor necrosis factor alpha can impact primary tumor growth and metastases through a host-mediated response (2007) (34)
Inherent cellular radiosensitivity of human tumors of varying clinical curability. (1976) (34)
Cross-talk between ceramide and PKC activity in the control of apoptosis in WEHI-231. (1996) (34)
Membrane-derived second messenger regulates x-ray-mediated tumor necrosis factor alpha gene induction. (1994) (34)
Survival and Analysis of Failure Following Hydroxyurea, 5‐Fluorouracil and Concomitant Radiation Therapy in Poor Prognosis Head and Neck Cancer (1991) (34)
The role of subcellular localization in assessing the cytotoxicity of iodine-125 labeled iododeoxyuridine, iodotamoxifen, and iodoantipyrine (1981) (34)
Biochemical Control and Toxicity after Intensity-Modulated Radiation Therapy for Prostate Cancer (2009) (34)
A randomized study comparing two regimens of neoadjuvant and adjuvant chemotherapy in multimodal therapy for locally advanced head and neck cancer (1990) (33)
Comutagenic effects of 3-aminobenzamide in Chinese hamster ovary cells. (1985) (33)
The immunology of ablative radiation. (2015) (33)
Receiver operating characteristic analysis: a general tool for DNA array data filtration and performance estimation. (2003) (33)
Overall survival according to immunotherapy and radiation treatment for metastatic non-small-cell lung cancer: a National Cancer Database analysis (2019) (33)
DNA Methylation Controls Metastasis-Suppressive 14q32-Encoded miRNAs. (2018) (33)
Fraction size and the repair of potentially lethal radiation damage in a human melanoma cell line. Possible implications for radiotherapy. (1982) (33)
Methotrexate, vinblastine, doxorubicin and cisplatin followed by radiotherapy or surgery for muscle invasive bladder cancer: the University of Chicago experience. (1993) (33)
How I do it: Head and neck and plastic surgery: Surgical management of the head and neck cancer patient following concomitant multimodality therapy (1995) (33)
Improved survival time trends for glioblastoma using the SEER 17 population-based registries. (2011) (33)
Investigation of the essential role of platelet-tumor cell interactions in metastasis progression using an agent-based model (2014) (33)
The role of intracellular calcium in the cellular response to ionizing radiation. (1994) (32)
Activation of the nuclear transcription factor κB (NFκB) and differential gene expression in U87 glioma cells after exposure to the cytoprotector amifostine (2002) (32)
Suppression of local type I interferon by gut microbiota–derived butyrate impairs antitumor effects of ionizing radiation (2021) (32)
Time-dose relationship for local tumor control following alternate week concomitant radiation and chemotherapy of advanced head and neck cancer. (1994) (32)
Release of spleen focus-forming virus (SFFV) from differentiation inducible promyelocytic leukemia cell lines transformed in vitro by Friend leukemia virus. (1980) (32)
Angiostatin induces mitotic cell death of proliferating endothelial cells. (2000) (32)
Treatment of perineural metastasis from squamous carcinoma of the skin with aggressive combination chemotherapy and irradiation (1985) (31)
Functional role for the c-Abl protein tyrosine kinase in the cellular response to genotoxic stress. (1997) (31)
HMG-CoA Reductase Inhibition Delays DNA Repair and Promotes Senescence After Tumor Irradiation (2017) (31)
Race and the Will Rogers phenomenon in prostate cancer. (1998) (31)
Photon neutron mixed-beam radiotherapy of locally advanced prostate cancer. (1995) (31)
Patterns of Failure After Radical Cystectomy for pT3-4 Bladder Cancer: Implications for Adjuvant Radiation Therapy. (2016) (31)
CDKN2A loss-of-function predicts immunotherapy resistance in non-small cell lung cancer (2021) (31)
The utility of FDG-PET for assessing outcomes in oligometastatic cancer patients treated with stereotactic body radiotherapy: a cohort study (2012) (31)
Increased oncolytic efficacy for high-grade gliomas by optimal integration of ionizing radiation into the replicative cycle of HSV-1 (2011) (30)
Cisplatin, 5‐fluorouracil, and high‐dose oral leucovorin for advanced head and neck cancer (1989) (30)
The patterns of failure in patients with pathological stage I and II diffuse histiocytic lymphoma treated with radiation therapy alone. (1989) (30)
Chemoinducible gene therapy: a strategy to enhance doxorubicin antitumor activity. (2004) (30)
Sequential induction chemotherapy and concomitant chemoradiotherapy in the management of locoregionally advanced laryngeal cancer. (2001) (30)
Response of human fibroblasts to low dose rate gamma irradiation. (1984) (30)
Attenuation of G2-phase cell cycle checkpoint control is associated with increased frequencies of unrejoined chromosome breaks in human tumor cells. (1996) (30)
Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced oropharyngeal cancer. (2001) (30)
The significance of positive chorionic gonadotropins in apparently pure seminoma of the testis. (1979) (30)
Potentially lethal damage repair as a possible determinant of human tumour radiosensitivity. (1984) (30)
Systemic delivery of (gamma1)34.5-deleted herpes simplex virus-1 selectively targets and treats distant human xenograft tumors that express high MEK activity. (2007) (30)
Prolonged treatment with angiostatin reduces metastatic burden during radiation therapy. (2003) (29)
In vitro radiobiological parameters of human sarcoma cell lines. (1988) (29)
A Manganese Superoxide Dismutase (SOD2)-Mediated Adaptive Response (2013) (29)
Tumor production of angiostatin is enhanced after exposure to TNF‐α (2002) (29)
Impact of radioimmunoscintigraphy on definition of clinical target volume for radiotherapy after prostatectomy. (2004) (29)
Adenovirally Delivered Tumor Necrosis Factor-α Improves the Antiglioma Efficacy of Concomitant Radiation and Temozolomide Therapy (2007) (28)
Radiation therapy with concomitant hydroxyurea and fluorouracil in stage II and III head and neck cancer. (1999) (28)
Neoadjuvant and adjuvant methotrexate, cisplatin, and fluorouracil in multimodal therapy of head and neck cancer. (1989) (28)
Defective reactivation of ultraviolet light-irradiated herpesvirus by a Bloom's syndrome fibroblast strain. (1979) (28)
Curative radiotherapy following chemotherapy for invasive bladder carcinoma (a preliminary report). (1991) (28)
Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: preliminary experience and future directions. (2006) (28)
Radiotherapy and immune checkpoint blockade: potential interactions and future directions. (2015) (28)
Effects of 17 beta-estradiol on radiation transformation in vitro; inhibition of effects by protease inhibitors. (1981) (28)
Race and competing mortality in advanced head and neck cancer. (2014) (28)
Superficial doses in treatment of breast with tangential fields using 4MV x-rays. (1977) (28)
Relevance and irrelevance of DNA damage response to radiotherapy. (2004) (28)
Improved survival for patients with advanced carcinoma of the head and neck treated with methotrexate‐leucovorin prior to definitive radiotherapy or surgery. (1981) (28)
Phorbol ester-induced monocytic differentiation is associated with G2 delay and down-regulation of cdc25 expression. (1993) (28)
Disparities in Treatment of Patients with Inoperable Stage I Non–Small Cell Lung Cancer: A Population-Based Analysis (2015) (27)
Repair of potentially lethal X ray damage and possible applications to clinical radiotherapy. (1983) (27)
Equivalent racial outcome after conformal radiotherapy for prostate cancer: a single departmental experience. (2001) (27)
Combined modality treatment of head and neck cancer with cisplatin, bleomycin, methotrexate‐leucovorin chemotherapy (1985) (27)
Concomitant chemoradiotherapy with cisplatin, 5‐fluorouracil and hydroxyurea in poor‐prognosis head and neck cancer (1992) (26)
Protection from Radiation-Induced Pulmonary Fibrosis by Peripheral Targeting of Cannabinoid Receptor-1. (2015) (26)
Retinoblastoma, chromosome 13, and in vitro cellular radiosensitivity. (1979) (26)
New findings in the chromosome 13 long-arm deletion syndrome and retinoblastoma. (1979) (26)
A phase I study of bevacizumab (B) with fluorouracil (F) and hydroxyurea (H) with concomitant radiotherapy (X) (B-FHX) for poor prognosis head and neck cancer (HNC). (2006) (26)
Prognostic indicators in node-negative early stage breast cancer. (1992) (26)
The interaction of 5-fluorouracil, hydroxyurea, and radiation in two human head and neck cancer cell lines. (1992) (25)
The role of DNA repair processes in the response of human tumors to fractionated radiotherapy. (1984) (25)
Footprinting of individual tumors and their variants by constitutive cytokine expression patterns. (1993) (25)
Combined gene therapy and ionizing radiation is a novel approach to treat human esophageal adenocarcinoma (2002) (25)
Vascular events in patients receiving high-dose infusional 5-fluorouracil-based chemotherapy: the University of Chicago experience. (1991) (25)
Modeling of dose to tumor and normal tissue from intraperitoneal radioimmunotherapy with alpha and beta emitters. (1990) (25)
Patterns of Distant Failure and Progression in Breast Cancer: Implications for the Treatment of Oligometastatic Disease (2011) (25)
Resveratrol is an effective inducer of CArG-driven TNF-α gene therapy (2008) (25)
The isoquinoline sulfonamide H7 attenuates radiation-mediated protein kinase C activation and delays the onset of x-ray-induced G2 arrest. (1992) (25)
Translational strategies exploiting TNF-α that sensitize tumors to radiation therapy (2009) (25)
Radiotherapy with concomitant chemotherapy for head and neck cancer. (1991) (24)
Oral PEG 15-20 protects the intestine against radiation: role of lipid rafts. (2009) (24)
False-Positive Phosphorus 32 Uptake Tests in the Diagnosis of Ocular Melanoma (1980) (24)
The role of paclitaxel in the treatment of head and neck cancer. (1995) (24)
Volumetric visualization of head and neck CT data for treatment planning. (1999) (24)
Racial parities in outcomes after radiotherapy for head and neck cancer (2014) (24)
SOD2-mediated adaptive responses induced by low-dose ionizing radiation via TNF signaling and amifostine. (2011) (24)
Adenoviral Transduction of Human Acid Sphingomyelinase into Neo-Angiogenic Endothelium Radiosensitizes Tumor Cure (2013) (24)
Radioresistance in some human tumor cells conferred in vitro by repair of potentially lethal X-ray damage. (1982) (23)
Everolimus exhibits efficacy as a radiosensitizer in a model of non-small cell lung cancer. (2012) (23)
Protection against AZT-induced mutagenesis at the HGPRT locus in a human cell line by WR-151326. (1992) (23)
Vascular endothelial growth factor pathway. (2010) (23)
Nfkb1 is a haploinsufficient DNA damage-specific tumor suppressor (2014) (23)
The effect of the alpha-emitting radionuclide lead-212 on human ovarian carcinoma: a potential new form of therapy. (1989) (23)
Effect of Bcl-2 on ionizing radiation and 1-beta-D-arabinofuranosylcytosine-induced internucleosomal DNA fragmentation and cell survival in human myeloid leukemia cells. (1993) (23)
Patterns of failure following total body irradiation and bone marrow transplantation with or without a radiotherapy boost for advanced neuroblastoma. (1995) (23)
Chromosome changes characterizing in vitro response to radiation in human squamous cell carcinoma lines. (1993) (23)
Ad.Egr-TNF and local ionizing radiation suppress metastases by interferon-beta-dependent activation of antigen-specific CD8+ T cells. (2010) (23)
Feasibility and toxicity of hypofractionated image guided radiation therapy for large volume limited metastatic disease. (2013) (23)
Radiation tolerance and the new biology: growth factor involvement in radiation injury to the lung. (1992) (23)
Radioimmunoscintigraphy for postprostatectomy radiotherapy: analysis of toxicity and biochemical control. (2004) (22)
Inhibition of spontaneous metastases formation by amifostine (2002) (22)
Advanced squamous carcinoma of the head and neck. A preliminary report of neoadjuvant chemotherapy with cisplatin, bleomycin, and methotrexate. (1984) (22)
Symmetrical chromosome rearrangements in cell lines established from human radiation-induced sarcomas. (1990) (22)
A Phase I trial assessing the safety and tolerability of a therapeutic DNA vaccination against HPV16 and HPV18 E6/E7 oncogenes after chemoradiation for cervical cancer. (2020) (22)
The syndrome of inappropriate antidiuretic hormone secretion associated with induction chemotherapy for squamous cell carcinoma of the head and neck (1986) (22)
A phase I dose escalation study of Ad GV.EGR.TNF.11D (TNFerade™ Biologic) with concurrent chemoradiotherapy in patients with recurrent head and neck cancer undergoing reirradiation. (2013) (22)
Uveal malignant melanoma in three generations of the same family. (1979) (21)
Breast conserving surgery and definitive irradiation for early stage breast cancer. (1989) (21)
Spleen cells from young but not old immunized mice eradicate large established cancers (2012) (21)
DNA damage-induced cytotoxicity is mediated by the cooperative interaction of phospho-NF-κB p50 and a single nucleotide in the κB-site (2012) (21)
Radiotherapy and immunotherapy converge on elimination of tumor-promoting erythroid progenitor cells through adaptive immunity (2021) (21)
MUC1-C Oncoprotein Interacts Directly with ATM and Promotes the DNA Damage Response to Ionizing Radiation. (2010) (21)
The effect of aging on the density and distribution of oral mucosal langerhans cells (1983) (21)
Different efficiencies of interaction between 3-aminobenzamide and various monofunctional alkylating agents in the induction of sister chromatid exchanges. (1985) (21)
The novel isocoumarin 2-(8-hydroxy-6-methoxy-1-oxo-1H-2-benzopyran-3-yl) propionic acid (NM-3) induces lethality of human carcinoma cells by generation of reactive oxygen species. (2001) (21)
Stress response genes induced in mammalian cells by ionizing radiation (1993) (21)
Oxidative Cell Membrane Alteration: Evidence for Surfactant‐Mediated Sealing a (1999) (21)
Influence of radioimmunoscintigraphy on postprostatectomy radiotherapy treatment decision making. (2004) (21)
Small cell carcinomas of the larynx: Results of combined modality treatments (1983) (20)
Expression of the polymorphic human DNA repair gene XRCC1 does not correlate with radiosensitivity in the cells of human head and neck tumor cell lines. (1992) (20)
Evidence for the expression of radiation-induced potentially lethal damage being a p53-dependent process. (2000) (20)
Image-Guided Radiotherapy Targets Macromolecules through Altering the Tumor Microenvironment. (2016) (20)
A phase 1 trial of autologous stem cell transplantation conditioned with melphalan 200 mg/m2 and total marrow irradiation (TMI) in patients with relapsed/refractory multiple myeloma (2018) (20)
Role of external beam radiotherapy with low-dose-rate brachytherapy in treatment of prostate cancer. (2006) (20)
Improved Survival Associated with Local Tumor Response Following Multisite Radiotherapy and Pembrolizumab: Secondary Analysis of a Phase I Trial (2020) (20)
JAK2 Inhibitor SAR302503 Abrogates PD-L1 Expression and Targets Therapy-Resistant Non–small Cell Lung Cancers (2018) (20)
Oligometastasis: Past, Present, Future. (2020) (20)
Prostate Cancer Outcomes Following Solid-Organ Transplantation: A SEER-Medicare Analysis. (2019) (20)
Ionizing radiation down-regulates histone H1 gene expression by transcriptional and post-transcriptional mechanisms. (1993) (20)
Prolonged c-jun expression in irradiated ataxia telangiectasia fibroblasts. (1996) (20)
Where It’s at Really Matters: In Situ In Vivo Vascular Endothelial Growth Factor Spatially Correlates with Electron Paramagnetic Resonance pO2 Images in Tumors of Living Mice (2010) (20)
Radiogenetic therapy: on the interaction of viral therapy and ionizing radiation for improving local control of tumors. (1997) (20)
A Phase I Trial of Concurrent Or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients with Stage IV Non-Small Cell Lung Cancer (COSINR Study). (2021) (19)
Membrane Permeability Changes in Gamma‐irradiated Muscle Cells a (1994) (19)
Initial Adjuvant Therapy in Advanced Squamous Cell Carcinoma of the Head and Neck Employing Weekly High Dose Methotrexate with Leucovorin Rescue (1978) (19)
The influence of initial pathologic stage on the survival of patients who relapse from Hodgkin's disease. (1980) (19)
Resveratrol is an effective inducer of CArG-driven TNF-alpha gene therapy. (2008) (19)
Mutation Spectrum of the p 53 Gene in Bone and Soft Tissue Sarcomas 1 (2006) (19)
The contribution of DNA ploidy to radiation sensitivity in human tumour cell lines (1999) (19)
Incidence and implications of oligometastatic breast cancer. (2012) (19)
DNA double-strand break rejoining rates, inherent radiation sensitivity and human tumour response to radiotherapy. (1996) (19)
Efficacy of Breast Conservation Therapy in Early Stage Bilateral Breast Cancer (1999) (19)
A hot spot for RAD51C interactions revealed by a peptide that sensitizes cells to cisplatin. (2004) (18)
Salvage radiotherapy after postprostatectomy biochemical failure: does pretreatment radioimmunoscintigraphy help select patients with locally confined disease? (2008) (18)
Effects of dexamethasone and cortisone with X-ray irradiation on transformation of C3H 10T1/2 cells (1981) (18)
Attenuated herpes simplex virus 1 blocks arterial apoptosis and intimal hyperplasia induced by balloon angioplasty and reduced blood flow (2007) (18)
Systemic miRNA delivery by nontoxic nanoscale coordination polymers limits epithelial-to-mesenchymal transition and suppresses liver metastases of colorectal cancer. (2019) (18)
Comparison of carboplatin-paclitaxel to docetaxel-cisplatin-5-flurouracil induction chemotherapy followed by concurrent chemoradiation for locally advanced head and neck cancer. (2014) (18)
The role of radiation therapy in the treatment of soft tissue sarcomas of childhood (1978) (18)
Strategies for enhancing viral-based gene therapy using ionizing radiation. (1999) (18)
Decoy Receptor DcR1 Is Induced in a p50/Bcl3-Dependent Manner and Attenuates the Efficacy of Temozolomide. (2015) (18)
Nanomedicine for Combination Therapy of Cancer (2015) (18)
Nanoscale metal-organic frameworks for x-ray activated in situ cancer vaccination (2020) (18)
Paclitaxel, 5-fluorouracil, hydroxyurea, and concomitant radiation therapy for poor-prognosis head and neck cancer. (1999) (18)
Treatment and Prognosis of Orbital Non‐Hodgkin's Lymphomas (1992) (18)
Characterization of response to radiation mediated gene therapy by means of multimodality imaging (2009) (18)
Characterization and radiobiologic parameters of medulloblastoma in vitro (1977) (18)
Radiation therapy in head and neck cancer: indications and limitations. (1994) (18)
Treatment selection in T1 and T2 vocal cord carcinoma. (1988) (18)
Ketoconazole attenuates radiation-induction of tumor necrosis factor. (1994) (18)
Heterogeneous response to X-ray and ultraviolet light irradiations of cultured skin fibroblasts in two families with Gardner's Syndrome. (1982) (18)
Hydroxyurea with concomitant radiotherapy for locally advanced head and neck cancer. (1992) (17)
Association between hospital volume and receipt of treatment and survival in patients with glioblastoma (2017) (17)
The AIM2 and NLRP3 inflammasomes trigger IL-1–mediated antitumor effects during radiation (2021) (17)
Angiostatin potentiates cyclophosphamide treatment of metastatic disease (2002) (17)
Efficacy of the Multi-Kinase Inhibitor Enzastaurin Is Dependent on Cellular Signaling Context (2010) (17)
Measurable impact: multimodality therapy of head and neck cancer. (1993) (17)
Molecular Classification of Lymph Node Metastases Subtypes Predict for Survival in Head and Neck Cancer (2018) (17)
Neoadjuvant PFL augmented by methotrexate and piritrexim followed by concomitant chemoradiotherapy for advanced head and neck cancer: a feasible and active approach. (1992) (17)
Activation of the nuclear transcription factor kappaB (NFkappaB) and differential gene expression in U87 glioma cells after exposure to the cytoprotector amifostine. (2002) (17)
Repurposing cephalosporin antibiotics as pro-senescent radiosensitizers (2016) (17)
Selective gene expression using a DF3/MUC1 promoter in a human esophageal adenocarcinoma model (2003) (16)
Hydroxyurea with continuous infusion paclitaxel, 5-fluorouracil, and concomitant radiotherapy for poor-prognosis head and neck cancer. (1995) (16)
Dose‐escalated radiation therapy for intermediate‐risk prostate cancer (2009) (16)
Multidisciplinary treatment of advanced squamous carcinoma of the head and neck. (1985) (16)
Abnormalities of human chromosome 13 and in vitro radiosensitivity; a study of 19 fibroblast strains. (1981) (16)
Methodological Development of Combination Drug and Radiotherapy in Basic and Clinical Research (2020) (16)
Dose-escalated radiotherapy for high-risk prostate cancer: outcomes in modern era with short-term androgen deprivation therapy. (2009) (16)
Prevalence and Predictors of Inappropriate Delivery of Palliative Thoracic Radiotherapy for Metastatic Lung Cancer. (2015) (16)
Definition, Biology, and History of Oligometastatic and Oligoprogressive Disease (2020) (16)
Author Correction: Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells (2019) (16)
Patterns of failure of complete responders following high-dose chemotherapy and autologous bone marrow transplantation for metastatic breast cancer: implications for the use of adjuvant radiation therapy. (1994) (16)
Molecular targets to overcome radioresistance. (1992) (15)
Integrating conventional and antibody-based targeted anticancer treatment into immunotherapy (2016) (15)
Lyn Tyrosine Kinase Inhibits Nuclear Export of the p53 Tumor Suppressor (2002) (15)
Transfer of Allogeneic CD4+ T Cells Rescues CD8+ T Cells in Anti-PD-L1–Resistant Tumors Leading to Tumor Eradication (2017) (15)
RIG-I–Like Receptor LGP2 Is Required for Tumor Control by Radiotherapy (2020) (15)
PSA-based outcome analysis after radiation therapy for prostate cancer: a new definition of biochemical failure after intervention. (1999) (15)
Significance of Family History in Breast Cancer Treated with Breast Conservation Therapy (1996) (15)
Modification by dexamethasone of radiation response of in vitro cultured cells. (1984) (15)
Synergistic cytotoxicity and DNA strand break formation by bromodeoxyuridine and bleomycin in human tumor cells. (1988) (15)
The oligometastatic spectrum in the era of improved detection and modern systemic therapy (2022) (14)
Chromosomal sensitivity of lymphocytes from individuals with therapy-related acute nonlymphocytic leukemia. (1989) (14)
Symposium: Adjuvant cancer therapy of head and neck tumors. Predefinitive and postdefinitive chemotherapy for locally advanced squamous carcinoma of the head and neck (1979) (14)
Synergistic checkpoint-blockade and radiotherapy–radiodynamic therapy via an immunomodulatory nanoscale metal–organic framework (2022) (14)
A downside to apoptosis in cancer therapy? (2011) (14)
Ionizing radiation-induced foci persistence screen to discover enhancers of accelerated senescence (2011) (14)
Radiation's outer limits (2005) (14)
Radiation therapy for pathologic stage III Hodgkin's disease with and without chemotherapy. (1989) (14)
ROS modifiers and NOX4 affect the expression of the survivin‐associated radio‐adaptive response (2018) (14)
DNA Repair Biomarkers XPF and Phospho-MAPKAP Kinase 2 Correlate with Clinical Outcome in Advanced Head and Neck Cancer (2014) (14)
Repair of fractionated radiation in plateau phase cultures of human tumor cells and human multicellular tumor spheroids. (1984) (14)
TP53 Mutational Status and ROS Effect the Expression of the Survivin-Associated Radio-Adaptive Response (2017) (14)
Systemic delivery of the tumor necrosis factor gene to tumors by a novel dual DNA-nanocomplex in a nanoparticle system. (2017) (13)
Increased injection number enhances adenoviral genetic radiotherapy. (1997) (13)
Radiotherapy and immunotherapy: open questions and future strategies. (2021) (13)
Occurrence of p 53 Gene Deletions and Human Papilloma Virus Infection in Human Head and Neck Cancer 1 (2006) (13)
An important step in radiation carcinogenesis may be inactivation of cellular genes. (1989) (13)
Estimates of dose to intraperitoneal micrometastases from alpha and beta emitters in radioimmunotherapy. (1991) (13)
S-phase-dependent p50/NF-кB1 phosphorylation in response to ATR and replication stress acts to maintain genomic stability (2015) (13)
Low Recombination Proficiency Score (RPS) Predicts Heightened Sensitivity to DNA-Damaging Chemotherapy in Breast Cancer (2017) (13)
Radioresistant derivatives of an X-ray-sensitive CHO cell line exhibit distinct patterns of sensitivity to DNA-damaging agents. (1990) (13)
Endothelial cells co‐cultured with wild‐type and dominant/negative p53‐transfected glioblastoma cells exhibit differential sensitivity to radiation‐induced apoptosis (2004) (13)
Familial retinoblastoma and ataxia telangiectasia human models for the study of DNA damage and repair (1980) (13)
Oncology Nurse (2003) (13)
Toxicity of aggressive multimodality therapy including cisplatinum, bleomycin and methotrexate with radiation and/or surgery for advanced head and neck cancer. (1982) (13)
Quantitation of the response of human tumor spheroids to daily radiation exposures. (1984) (13)
Cytoreduction and the Optimization Of Immune Checkpoint Inhibition with Radiation Therapy. (2020) (13)
A randomized study of inpatient versus outpatient continuous intravenous infusion chemotherapy: psychosocial aspects. (1989) (13)
Perspectives on combination chemotherapy with concomitant radiotherapy for poor-prognosis head and neck cancer. (1992) (13)
Blockage of the Early Events of Mitogenic Signaling by Interferon-γ in Macrophages in Response to Colony-Stimulating Factor-1 (1995) (13)
Concomitant chemoradiotherapy, neutron boost, and adjuvant chemotherapy for anaplastic astrocytoma and glioblastoma multiforme. (1995) (13)
Letter: Gamma-irradiation of mammalian beating heart cells in vitro. Effects on cellular function. (1975) (13)
Radiation therapy in the treatment of cervical Cancer: The university of Chicago/Michael reese hospital experience (1990) (13)
Cellular and molecular mechanisms of radioresistance. (1995) (13)
Platelet-derived growth factor stimulates bone resorption by monocyte monolayers. (1983) (12)
Radiation-induced tumor dormancy reflects an equilibrium between the proliferation and T lymphocyte-mediated death of malignant cells (2013) (12)
Development of additional primary tumors after 62 years in the first patient with retinoblastoma cured by radiation therapy. (1984) (12)
Radiation can inhibit tumor growth indirectly while depleting circulating leukocytes. (1996) (12)
The evolution of combination therapy of genitourinary rhabdomyosarcoma in children: a preliminary report. (1977) (12)
Measurement of weekly prostate specific antigen levels in patients receiving pelvic radiotherapy for nonprostatic malignancies. (1995) (12)
Lung cancer : a comprehensive treatise (1988) (12)
Treatment of head and neck and esophageal xenografts employing Alimta and concurrent ionizing radiation. (2001) (12)
DDX39B interacts with the pattern recognition receptor pathway to inhibit NF-κB and sensitize to alkylating chemotherapy (2020) (12)
Differing patterns of cytotoxicity of the phorbol ester 12-O-tetradecanoylphorbol 13-acetate in various human cell strains. (1985) (11)
Autologous Bone Marrow Transplantation Followed by Involved Field Radiotherapy in Patients with Relapsed or Refractory Hodgkin's Disease. (1991) (11)
Potentially lethal damage repair (PLDR) in X-irradiated cultures of a normal human diploid fibroblast cell strain. (1983) (11)
Measurement of bioreduction rates of cells with distinct responses to ionizing radiation and cisplatin. (1991) (11)
Staging the Metastatic Spectrum Through Integration of Clinical and Molecular Features. (2019) (11)
More on cetuximab in head and neck cancer. (2007) (11)
Investigation of the cytotoxic effects of DNA damaging agents on neurofibromatosis cells. (1985) (11)
The effect of radiotherapy dose on survival in stage III non-small-cell lung cancer patients undergoing definitive chemoradiotherapy. (2014) (11)
Repair of potentially lethal X-ray damage in fibroblasts derived from patients with hereditary and D-deletion retinoblastoma. (1985) (11)
Type 3 innate lymphoid cell-derived lymphotoxin prevents microbiota-dependent inflammation (2018) (11)
Evolution of toxicity after conformal radiotherapy for prostate cancer (2002) (11)
Chemotherapy for advanced carcinoma of the head and neck. A clinical update. (1981) (11)
Progression of cancer from indolent to aggressive despite antigen retention and increased expression of interferon-gamma inducible genes. (2011) (11)
Ad.Egr-TNF and Local Ionizing Radiation Suppress Metastases by Interferon-β-Dependent Activation of Antigen-specific CD8+ T Cells. (2010) (11)
Monosomy 12p in a radiation‐induced germ cell tumor (1990) (11)
Concomitant Hydroxyurea, 5-Fluorouracil, and Radiation Therapy for Recurrent Head and Neck Cancer: Early Results (1988) (11)
4-Hydroxyacetophenone modulates the actomyosin cytoskeleton to reduce metastasis (2020) (11)
All-trans retinoic acid overcomes solid tumor radioresistance by inducing inflammatory macrophages (2021) (11)
Basal Tumor Cell Isolation and Patient-Derived Xenograft Engraftment Identify High-Risk Clinical Bladder Cancers (2016) (11)
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two (2016) (11)
Preliminary results of aggressive multimodality therapy for metastatic osteosarcoma (1977) (11)
Gene therapy enhances the antiproliferative effect of radiation in intimal hyperplasia. (2000) (10)
Antimetastatic effectiveness of amifostine therapy following surgical removal of Sa-NH tumors in mice. (2002) (10)
Continuous infusion paclitaxel, 5-fluorouracil, and hydroxyurea with concomitant radiotherapy in patients with advanced or recurrent head and neck cancer. (1997) (10)
Prospects for viral-based strategies enhancing the anti-tumor effects of ionizing radiation. (2001) (10)
Clonal interactions in a human squamous cell carcinoma. (1995) (10)
Enhancing radiotherapy with genetically engineered viruses. (2007) (10)
Effects of estradiol concentration on levels of nuclear estrogen receptors in MCF-7 breast tumor cells. (1984) (10)
Antipain-mediated suppression of sister chromatid exchanges induced by an inhibitor of poly (ADP-ribose) polymerase. (1985) (10)
Very low doses of ionizing radiation and redox associated modifiers affect survivin-associated changes in radiation sensitivity. (2016) (10)
Adjuvant radiotherapy for resected pancreatic cancer: a lack of benefit or a lack of adequate trials? (2009) (10)
Oct-1 Is Posttranslationally Modified and Exhibits Reduced Capacity To Bind Cognate Sites at Late Times after Infection with Herpes Simplex Virus 1 (2003) (10)
Concomitant proliferation and caspase-3 mediated apoptosis in response to low shear stress and balloon injury. (2010) (10)
EVALUATION OF DIFFERENT IN VITRO ASSAYS OF INHERENT SENSITIVITY AS PREDICTORS OF RADIOTHERAPY RESPONSE (1991) (10)
(Oligo)metastasis as a Spectrum of Disease (2021) (10)
Sustained inhibition of experimental neointimal hyperplasia with a genetically modified herpes simplex virus. (2003) (10)
Tumor genotype determines susceptibility to oncolytic herpes simplex virus mutants: strategies for clinical application. (2007) (9)
Medical Innovation and the Critical Role of Health Technology Assessment (1999) (9)
Bilateral Malignant Choroidal Melanomas (1980) (9)
Interstitial deletion of chromosome 13 and associated congenital anomalies (1979) (9)
Principles of Oncology Nursing (2000) (9)
Nonmuscle Myosin Light Chain Kinase Activity Modulates Radiation-Induced Lung Injury (2016) (9)
Genomic profiling of kinase genes in head and neck squamous cell carcinomas to identify potentially targetable genetic aberrations in FGFR1/2, DDR2, EPHA2, and PIK3CA. (2013) (9)
Proliferation kinetics of a human breast cancer line in vitro following treatment with 17beta-estradiol and 1-beta-D-arabinofuranosylcytosine. (1978) (9)
5-fluorouracil, leucovorin, hydroxyurea, and escalating doses of continuous-infusion cisplatin with concomitant radiotherapy: a clinical and pharmacologic study (2004) (9)
Long-term outcome of re-irradiation with concomitant chemotherapy for locally recurrent squamous cell carcinoma of the head and neck (2003) (9)
Radioresistant tumor cell lines derived from head and neck radiation failures (1989) (9)
Highly aneuploid non-small cell lung cancer shows enhanced responsiveness to concurrent radiation and immune checkpoint blockade. (2022) (8)
Reprogramming of Neutrophils as Non-canonical Antigen Presenting Cells by Radiotherapy-Radiodynamic Therapy to Facilitate Immune-Mediated Tumor Regression. (2021) (8)
The role of post‐operative radiation therapy in the treatment of malignant tumors of the parotid gland (1984) (8)
How does antiangiogenic therapy affect brain tumor response to radiation? (2005) (8)
Recent advances in radiation therapy for head and neck cancer. (1991) (8)
An in vitro investigation of genetic susceptibility to cancer in diploid fibroblasts from retinoblastoma patients. (1980) (8)
Zinc cyclic di-AMP nanoparticles target and suppress tumours via endothelial STING activation and tumour-associated macrophage reinvigoration (2022) (8)
Activation of protein kinase C d by the c-Abl tyrosine kinase in response to ionizing radiation (1998) (8)
Survival outcomes for postoperative chemoradiation in intermediate‐risk oral tongue cancers (2017) (8)
Diverse TNFα-induced death pathways are enhanced by inhibition of NF-κB (2007) (8)
Role of Chemotherapy in the Multidisciplinary Approach to Advanced Head and Neck Cancer: Potentials and Problems (1981) (8)
Enterococcus faecalis promotes a migratory and invasive phenotype in colon cancer cells (2022) (8)
Phosphorous metabolite and cell cycle kinetic response of two human squamous cell carcinomas to radiation. (1992) (8)
A link between calcitriol and bone resorption. (1988) (8)
Membrane permeability changes in gamma-irradiated muscle cells. (1994) (8)
DEFECTIVE HOST-CELL REACTIVATION OF UV-IRRADIATED HERPES SIMPLEX VIRUS BY BLOOM'S SYNDROME SKIN FIBROBLASTS (1978) (8)
Initial adjuvant weekly high dose methotrexate with leucovorin rescue in advanced squamous carcinoma of the head and neck. (1978) (8)
Dual Induction of the Epo-Egr-TNF-α Plasmid in Hypoxic Human Colon Adenocarcinoma Produces Tumor Growth Delay (2003) (8)
Principles of Cancer Rehabilitation Medicine (2000) (8)
In Vitro Studies of Fibroblasts from Patients with Retinoblastoma (1980) (8)
Role of GADD45a in murine models of radiation- and bleomycin-induced lung injury. (2015) (7)
Radiation-inducible gene therapy. (1999) (7)
Radiotherapy and Immunotherapy Combinations in the Treatment of Patients with Metastatic Disease: Current Status and Future Focus (2021) (7)
microRNAs and oligometastasis (2015) (7)
Work in progress: radioprotection of human breast cancer cells by elevation of intracellular cyclic AMP. (1983) (7)
The mechanism of 3-aminobenzamide-mediated increases in spontaneous and induced SCEs. (1984) (7)
Cooperation of genes in HPV16 E6/E7-dependent cervico-vaginal carcinogenesis trackable by endoscopy and independent of exogenous estrogens or carcinogens. (2020) (7)
Selective Gene Expression (1998) (7)
Diverse TNFalpha-induced death pathways are enhanced by inhibition of NF-kappaB. (2007) (7)
Tumor‐Activatable Nanoparticles Target Low‐Density Lipoprotein Receptor to Enhance Drug Delivery and Antitumor Efficacy (2022) (7)
Twice-a-day fractionation preoperative radiotherapy in patients with carcinoma of the bladder: preliminary report. (1981) (7)
Repurposing Drugs for Cancer Radiotherapy: Early Successes and Emerging Opportunities (2019) (7)
CDK1 is up-regulated by temozolomide in an NF-κB dependent manner in glioblastoma (2021) (7)
Blockage of the early events of mitogenic signaling by interferon-gamma in macrophages in response to colony-stimulating factor-1. (1995) (7)
Stereotactic body radiotherapy for oligometastatic breast cancer: a new standard of care, or a medical reversal in waiting? (2016) (7)
Radiation therapy for the treatment of benign locally aggressive fibromatosis (1980) (7)
Poly (ADP-ribose) polymerase inhibitor efficacy in head and neck cancer. (2014) (6)
Imaging of tumor clones with differential liver colonization (2015) (6)
Chemotherapeutic and biologic radiation enhancement (1991) (6)
2006 Efficacy of breast conservation therapy in early stage bilateral breast cancer (1996) (6)
Expression and mutational analysis of c-CBL and its relationship to the MET receptor in head and neck squamous cell carcinoma (2016) (6)
Phase I Study of Stereotactic Body Radiotherapy plus Nivolumab and Urelumab or Cabiralizumab in Advanced Solid Tumors (2021) (6)
Growth factors alter the therapeutic ratio in radiotherapy. (1995) (6)
Complications of Cancer Therapy (1980) (6)
Cellular and molecular aspects of human tumor radioresistance. (1991) (6)
The Change of Soluble Programmed Cell Death-Ligand 1 in Glioma Patients Receiving Radiotherapy and Its Impact on Clinical Outcomes (2020) (6)
Advanced Animal Model of Colorectal Metastasis in Liver: Imaging Techniques and Properties of Metastatic Clones. (2016) (6)
Gene therapy: the challenges of translating laboratory research into clinical practice. (2003) (6)
MUC 1-Associated Proliferation Signature Predicts Outcomes in Lung Adenocarcinoma Patients (2010) (6)
Small animal IMRT using 3D printed compensators. (2020) (6)
Protease inhibitor antipain reduces nuclear binding of estrogen-receptor complex in MCF-7 breast tumor cells. (1984) (6)
Fibroblast radiosensitivity and intraocular fibrovascular proliferation following radiotherapy for bilateral retinoblastoma. (1986) (6)
The differential diagnosis of the mass in the neck. A fresh look (1981) (6)
Mutation Does Not Correlate with Radiosensitivity in 24 Head and Neck Cancer Cell Lines 1 (2006) (5)
An in vitro investigation of x-ray sensitivity in fibroblasts from patients with retinoblastoma. (1983) (5)
Author Correction: Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis (2018) (5)
Cisplatin, 5-fluorouracil, and high-dose oral leucovorin for advanced head and neck cancer. (1989) (5)
Role of gene therapy in radiation oncology. (1998) (5)
Modulation of apoptotic response of a radiation-resistant human carcinoma by Pseudomonas exotoxin-chimeric protein. (1998) (5)
Growth and Magnetic Resonance Characteristics of Human Squamous Cell Carcinoma Xenografts Implanted with Cells Suspended in MatrigelTM (1993) (5)
The Use of Pre-operative Radiation Therapy in the Treatment of Lung Carcinoma (1981) (5)
p50 mono-ubiquitination and interaction with BARD1 regulates cell cycle progression and maintains genome stability (2020) (5)
Possible applications of biotechnology to radiotherapy. (1991) (5)
Does the sequencing of radiotherapy and chemotherapy affect the outcome in earlystage breast cancer: A continuing question (1994) (5)
Safety and Efficacy of a Randomized Phase I Trial to Evaluate Concurrent or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Patients with Stage IV Non-small Cell Lung Cancer (COSINR Study) (2020) (5)
X-RAY SENSITIVITY OF FIBROBLASTS FROM PATIENTS WITH RETINOBLASTOMA AND WITH ABNORMALITIES OF CHROMOSOME 13 (1978) (5)
Multimodality Management of Orbital Rhabdomyosarcoma (1980) (5)
Advances regarding the pathogenesis and treatment of ocular tumors. (1980) (5)
50 Localized subcutaneous soft tissue sarcoma: Implications for the use of adjuvant radiation therapy (1995) (5)
Multi-Site SBRT and Sequential Pembrolizumab: Treated Metastasis Control and Immune-Related Expression Predict Outcomes (2019) (5)
Racial differences in prostate-specific antigen levels in patients with local-regional prostate cancer. (1992) (5)
The Spectrum of Metastasis: An Opportunity for Cure? (2021) (5)
Timing and sequencing of chemoradiotherapy. (1995) (4)
Is pelvic irradiation necessary in stage III1A Hodgkin's disease? (1990) (4)
Radioresistant derivatives of radiosensitive CHO cells obtained following treatment with 5-azacytidine retain their sensitivity to cisplatin. (1991) (4)
Fibroblast Radiosensitivity and Intraocular Fibrovascular Proliferation following Radiotherapy for Bilateral Retinoblastoma (1986) (4)
Prospective clinical investigation of the efficacy of combination radiotherapy with immune checkpoint inhibition. (2021) (4)
Involvement of reactive oxygen intermediates in the induction of c-jun gene transcription by ionizing radiation. [Erratum to document cited CA117(15):146279d] (1992) (4)
Patterns Of Progression Following Hypofractionated Image-guided Radiotherapy (HIGRT) To Abdominal Lymph Nodes In Oligometastatic (OM) Patients (2011) (4)
Tumor aneuploidy predicts survival following immunotherapy across multiple cancers (2022) (4)
Acute toxicity in radiotherapy of prostate cancer: Results of a randomized study with and without beam's‐eye view three‐dimensional conformal therapy (1996) (4)
Bugging the intestinal response to radiation. (2005) (4)
Similar sensitivity of human lymphoblast cells proficient or deficient in nucleotide biosynthesis to the cytotoxic and cell cycle effects of 3-aminobenzamide. (1985) (4)
Electron Paramagnetic Resonance Oxygen Images Correlates Spatially and Quantitatively with Increased Vascular Endothelial Growth Factor Concentrations (2009) (4)
Control of gene therapy by MDR1 and EGR1 promoter sequences in transcriptional targeting by chemotherapy (Review). (2004) (4)
Analysis of Radiation Pneumonitis (RP) Incidence in a Phase I Stereotactic Body Radiotherapy (SBRT) Dose Escalation Study for Multiple Metastases (2010) (4)
2564 : Phase I Dose Escalation of Hypofractionated Radiation Therapy for Patients With Oligometastasis (2006) (4)
Treatment of Cancer with Radio-Immunotherapy: What We Currently Know and What the Future May Hold (2021) (4)
Combined modality treatment of head and neck cancer with cisplatin, bleomycin, methotrexate-leucovorin chemotherapy. (1986) (4)
69 Risk of late bladder and rectal complications following definitive radiation therapy for carcinoma of the cervix: A dosimetric analysis (1995) (4)
Cytogenetic, Cytotoxic, and Cell-Cycle Effects of 3-Aminobenzamide in Human Lymphoblastoid Cells Proficient or Deficient in Nucleotide Biosynthesis (1985) (4)
Radiation targeting of gene therapy is preferentially cytotoxic to tumor cells (1994) (4)
Management of stage I and II Hodgkin's disease. (1989) (4)
Is It Worth It? Consequences of Definitive Head and Neck Reirradiation. (2020) (4)
Chemoinducible gene therapy (2005) (4)
Abstract 3405: MicroRNA expression characterizes oligometastasis(es) (2012) (4)
Small molecule derived from a natural product that mitigates radiation injury (2013) (3)
Chemo-inducible gene therapy. (2005) (3)
Principles of Bone Marrow Transplantation (2000) (3)
Biologic Basis of Radiation Therapy (2003) (3)
MG ATP AND ANTIOXIDANTS AUGMENT THE RADIOPROTECTIVE EFFECT OF SURFACTANT COPOLYMERS (2011) (3)
Response Letter: Radiation therapy for COVID-19 pneumopathy (2020) (3)
Long-term Survivors of an SBRT Dose-Escalation Study for Oligometastases: Clinical and Molecular Markers (2015) (3)
IN VITRO RADIOSENSITIVITY OF FIBROBLASTS DERIVED FROM PATIENTS WITH RETINOBLASTOMA AND ABNORMALITIES OF CHROMOSOME 13 (1983) (3)
Effects of serum-free defined medium on MCF-7 cell nuclear estrogen-receptor levels (1982) (3)
2056 The impact of race on biochemical outcome in patients receiving irradiation for prostate cancer (1996) (3)
Differential retention of tumor‐ and differentiation‐suppressor functions in cells derived from a human squamous cell carcinoma (1992) (3)
Long-term culture of human granulocytes and granulocyte progenitor cells. (1986) (3)
Tumor size does not limit radiation-inducible gene therapy in a human xenograft model (1995) (3)
Angiogenesis inhibition: the next frontier in multimodal therapy for glioblastoma multiforme (2007) (3)
Modern Radiation Therapy and Cardiac Outcomes in Breast Cancer (2016) (3)
A phase 1 trial utilizing TMI with fludarabine-melphalan in patients with hematologic malignancies undergoing second allo-SCT (2022) (3)
Phase I dose-escalation study of tumor necrosis factor-α gene transfer with radiation therapy for advanced solid tumors (2001) (3)
Initial relapses in previously treated Hodkin's disease (1979) (3)
Quality of life (QL) and performance outcome in survivors of concomitant chemoradiotherapy protocols for head and neck cancer (HNC) (Meeting abstract). (1997) (3)
Effect of postradiotherapy neck dissection on nonregional disease sites. (2014) (3)
P13 01 MP – ALTERED REGULATION OF A HUMAN GENE INDUCED BY IONIZING RADIATION IN TUMOR CELL LINES (1991) (3)
Induction and repair of dna strand breaks in human tumor cells (1987) (3)
Forphenicinol enhances the antitumor effects of cyclophosphamide in a model of squamous cell carcinoma (2005) (3)
66 Delivery of radiation inducible gene therapy using the replication deficient adenovirus type 5 (1995) (3)
Combination hormonal, chemotherapy and radiotherapy in vitro: implications for therapy in vivo. (1979) (3)
The treatment of stage III non-small cell lung cancer (NSCLC) using high dose conformal radiotherapy (CRT) (1993) (3)
EPR oxygen images predict tumor control by a 50 percent tumor control radiation dose (2013) (3)
Cell biological effects of total body irradiation on growth and differentiation of acute myelogenous leukemia cells compared to normal bone marrow. (1979) (3)
Outcomes in black patients with early breast cancer treated with breast conservation therapy. (2011) (3)
Beyond Palliation: The Rationale for Metastasis-Directed Therapy for Metastatic Non-Small Cell Lung Cancer. (2019) (3)
Palliative radiotherapy. (1990) (3)
Stereotactic radiotherapy for pulmonary metastases. (2013) (3)
Modulating vascular intimal hyperplasia using HSV-1 mutant requires activated MEK (2012) (2)
Section 31: The Breast (2003) (2)
S09 01 MA – TRANSCRIPTIONAL INDUCTION OF EARLY RESPONSE GENES BY X-RAYS (1991) (2)
The Oncology Pharmacist (2003) (2)
STING (or SRC) Like an ICB: Priming the Immune Response in Pancreatic Cancer. (2019) (2)
Sensitivities of NIH / 3 T 3-derived Clonal Cell Lines to Ionizing Radiation : Significance for Gene Transfer Studies 1 (2006) (2)
27 Patterns of failure following high-dose chemotherapy and stem cell rescue for relapsed/refractory non-Hodgkin's lymphoma: Implications for the use of adjuvant involved field radiotherapy (1996) (2)
Optimizing management of colorectal hepatic metastases: now and in the future. (2014) (2)
Chromosome 3 p Deletions in Head and Neck Carcinomas : Statistical Ascertainment of Allelic Loss 1 (2006) (2)
Possible racial differences in prostate specific antigen (PSA) levels in patients with local-regional prostate cancer (1991) (2)
DNA Damage and Repair in the Clinic (1998) (2)
Patterns of failure of complete responders following high dose chemotherapy and autologous bone marrow transplantation for metastatic breast cancer: The role of adjuvant local irradiation (1993) (2)
Principles of Cancer Pathology (2000) (2)
43 Angiogenesis as predictor of long term survival in patients with node-negative breast cancer (1996) (2)
136 Tissue specific promoters improve the localization of radiation-inducible gene expression (1996) (2)
Issues of controversy in radiation therapy and combined modality approaches to Hodgkin's disease. (1979) (2)
Techniques for localized radiation of carcinoma of the biliary tree (1979) (2)
Gene Delivery Systems (2003) (2)
Mutations of the p53 tumor suppressor gene may predict radiotherapy failure in head and neck cancer patients (1992) (2)
Substaging of stage III Hodgkin's disease. (1989) (2)
Critical Role Of Sphingolipid Pathway Components In Murine Radiation-Induced Lung Injury: Protection By Sphingosine 1 Phosphate Analogues (2011) (2)
The Rehabilitation Specialist (2003) (2)
2044 Early and late toxicity of involved-field radiation therapy in conjunction with high-dose chemotherapy and stem cell rescue (1995) (2)
Phase II Prospective, Open-Label Randomized Controlled Trial Comparing Standard of Care Chemotherapy With and Without Sequential Cytoreductive Interventions for Patients with Oligometastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor Deoxyribose Nucleic Acid (ctDNA) Levels (2022) (2)
A Phase II trial of induction Cisplatin, 5-FU, Leucovorin, and Interferon α-2B (PFL-α) followed by concurrent Hydroxyurea, 5-FU and radiation for Stage IV squamous cell cancers of the head and neck (HNC) (1994) (2)
A technique for developing established cell lines from human osteosarcomas (1976) (2)
A Three-in-One Nanoscale Coordination Polymer for Potent Chemo-Immunotherapy. (2023) (2)
Radiation therapy for non-Hodgkin's lymphoma. (1979) (2)
Modulation of vascular remodeling induced by a brief intraluminal exposure to the recombinant R7020 strain of Herpes simplex-1. (2005) (2)
Significance of family history in early stage breast cancer treated with breast conservation therapy (1994) (2)
Radioimmunoscintigraphy for post-prostatectomy radiotherapy: Analysis of toxicity and biochemical control. (2004) (2)
Phase I dose escalation study of tumor necrosis factor and radiation (1993) (2)
Radiotherapy without Toxicity NM-3 , an Isocoumarin , Increases the Antitumor Effects of Updated Version (2000) (2)
Beam's eye view (BEV) based photon radiotherapy: Report of two years experience in 154 patients (1990) (2)
Twice-daily re-irradiation of recurrent and second primary head and neck cancer with gemcitabine, paclitaxel and fluorouracil chemoradiotherapy. (2004) (2)
The role of chemotherapy for advanced carcinoma of the supraglottic and glottic larynx. (1984) (2)
Breast recurrence after conservative surgery and radiotherapy: Management and predictive factors for outcome (1994) (2)
88 Results of aggressive reirradiation with concomitant chemotherapy in recurrent unresectable head and neck cancer (HNC) (1996) (2)
1057 Forty-year follow up of bilateral breast cancer treated with mastectomy: The prognostic value of elapsed interval between the two breast primaries (1996) (2)
Sunitinib-Loaded Chondroitin Sulfate Hydrogels as a Novel Drug-Delivery Mechanism for the Treatment of Pancreatic Neuroendocrine Tumors (2021) (2)
Radioresistant and repair proficient tumor cells may be associated with local failure in head and neck cancer (1986) (1)
The utility of FDG-PET for assessing outcomes in oligometastatic cancer patients treated with stereotactic body radiotherapy: a cohort study (2012) (1)
2879: Characterization of Dose Enhancement Produced by Nanoparticles (2006) (1)
137 Enhanced tumor control of human glioblastoma multiforme xenografts with the concomitant use of radiotherapy and an attentuated herpes simplex-1 virus (ASTRO Research Fellowship) (1996) (1)
Southern analysis of human head and neck cancer cells for homologous sequences using yeast gamma repair genes (1988) (1)
Intensified and accelerated concomitant chemoradiotherapy and G-CSF for locally advanced head and neck cancer (1993) (1)
Combined radio-immunotherapy: An opportunity to increase the therapeutic ratio of oligometastasis-directed radiotherapy (2022) (1)
Alterations of the retinoblastoma recessive oncogene in the etiology of osteo and soft tissue sarcoma (1989) (1)
Immunotherapy for the Neoadjuvant Management of Resectable Intrathoracic Cancers: Let's Not Forget Radiotherapy. (2022) (1)
Response to editorial by Harari and Fowler (1994) (1)
Cancer of the Upper Gastrointestinal Tract (2002) (1)
Platinum complexes inhibit repair of potentially lethal damage following bleomycin treatment. (1987) (1)
Establishment of a syngeneic model of hepatic colorectal oligometastases. (2006) (1)
Molecular Pathways Molecular Pathways : Interferon / Stat 1 Pathway : Role in the Tumor Resistance to Genotoxic Stress and Aggressive Growth (2012) (1)
Attempts at cloning genes responsible for radioresistance in human tumors (1986) (1)
Protective Effects of Simvastatin in a Murine Model of Radiation-Induced Lung Injury (RILI). (2009) (1)
Epigenetic effects on radiosensitivity: the extracellular matrix and growth factors. (1992) (1)
Section 1: Cancer Biology (2003) (1)
Sequential administration of methotrexate, cisplatin, and 5-fluorouracil in multimodal therapy for locally advanced head and neck cancer. (1988) (1)
Medical Oncologist (2003) (1)
WHERE DO RADIORESISTANT CELLS COME FROM (1992) (1)
Combined modality treatment of advanced head and neck cancer (1984) (1)
Inhibition of Nuclear Factor-KB Activity by Temozolomide Involves O 6 -Methylguanine-Induced Inhibition of p65DNA Binding (2007) (1)
Differential expression of the c-jun proto oncogene during the cellular response to ionizing radiation is deminished by protein kinase C inhibitors (1990) (1)
Modification of anti-oxidant enzymatic activity by low dose selenium supplementation does not affect radiosensitivity of human malignant glioma cells (1998) (1)
Metastasis. (2022) (1)
Strategies for Combining Gene Therapy with Ionizing Radiation to Improve Antitumor Efficacy (2002) (1)
Loss of MEN1 function impairs DNA repair capability of pancreatic neuroendocrine tumors. (2022) (1)
High dose methotrexate with leukovorin rescue as initial adjuvant therapy in advanced local squamous cell carcinoma of the head & neck (1977) (1)
Application of moiré photography to multi-level treatment planning in radiation therapy of the intact breast (1987) (1)
The patterns of failure following total body irradiation and bone marrow transplantation +/− local radiotherapy boost for advanced neuroblastoma (1994) (1)
Expression and methylation of the Blym gene in human tumor cell lines. (1987) (1)
Programs of Epidermal Differentiation Associated with the Suppression of the Transcriptional Progression of Barrett ' s Metaplasia to Adenocarcinoma Is (2005) (1)
Proteolytic activation ofprotein kinase C 8 byan ICE-like protease inapoptotic cells (1995) (1)
Section 23: Central Nervous System (2003) (1)
Response to Emami (1992) (1)
Non-Muscle Myosin Light Chain Kinase Participates In Tumor Metastasis In Mice (2011) (1)
Comprar Holland-Frei Cancer Medicine 8th | Waun Ki Hong | 9781607950141 | Mcgraw-Hill Education (2010) (1)
2082 A pilot study on the use of volume visualization in image-based treatment planning for head and neck cancer (1995) (1)
Section 3: Cancer Etiology (2003) (1)
Section 34: Hematopoietic System (2003) (1)
Molecular basis for the use of glucocorticoids, nonsteroidals and pentoxifylline to minimize the acute effects of radiotherapy (1992) (1)
Induces c-jun Expression in Human Myeloid Leukemia Cells : Potential Involvement of a Protein Kinase C-dependent Signaling Pathway 1 (2006) (1)
What is a surgical oncologist? (2006) (1)
Correction: Oligo- and Polymetastatic Progression in Lung Metastasis(es) Patients Is Associated with Specific MicroRNAs (2013) (1)
Abstract 44: STAT1-dependent expression of genes and proteins involved in energy metabolism links tumor growth and radioresistance to the Warburg effect and predicts poor prognosis in cancer patients (2010) (1)
Comparative analysis of the inherent radiosensitivity of ovarian carcinoma. (1989) (1)
Coronavirus Disease 2019 Infection Prevention and Control Practices in Wuhan Radiation Therapy (2020) (1)
Safety and clinical activity of pembrolizumab immunotherapy and multi-organ site ablative stereotactic body radiotherapy (iMOSART) in patients with advanced solid tumors. (2018) (1)
Radiobiologic research for head and neck cancer therapy. Therapeutic implications. (1983) (1)
TLR3 agonist nanoscale coordination polymer synergizes with immune checkpoint blockade for immunotherapy of cancer. (2022) (1)
Does Cetuximab Improve Control of Advanced Head and Neck Cancer? A Second Look at the Randomized Trial by Bonner, et al. (2007) (1)
Rhythmic radiotherapy beats down TGF-β. (2017) (1)
Hepatic metastases: Treatment with radiation therapy (1977) (1)
Fecal microbiota transplant rescues mice from human pathogen mediated sepsis by restoring systemic immunity (2020) (1)
The management of hepatic metastases: the role of radiation therapy (1977) (1)
Nanoparticle-Mediated Radiotherapy Remodels the Tumor Microenvironment to Enhance Antitumor Efficacy. (2022) (1)
Long-term experience with cisplatin-based induction chemotherapy and concomitant chemoradiotherapy in locally advanced head and neck cancer (HNC) (1993) (1)
Association of Statins with Biochemical Failure after Radiotherapy for Prostate Cancer (2008) (1)
88 Decreasing the apoptotic threshold with chelerythrine chloride enhances radiation cures in vivo (1997) (1)
Time-dose analysis of local control for advanced head and neck neoplasms treated with concomitant chemoradiotherapy on an alternate week schedule (1993) (1)
Importance of repair of potentially lethal damage in assays of cytotoxic agents. (1982) (0)
Section 21: Pain and Palliation (2003) (0)
Cancer Gene Therapy (2003) (0)
Anti-Leukemic Activity Is Increased with Low Dose Busulfan and Irradiation: A Preclinical Model (2011) (0)
Section 36: Unknown Primary Site (2003) (0)
Targeting of gene therapy with radiation therapy (1992) (0)
Abstract 262: O6-methylguanine:Deoxythymidine mismatches sensitize cells to DNA strand break-induced cytotoxicity (2012) (0)
Section 39: Infection in the Cancer Patient (2003) (0)
Author Correction: Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells (2019) (0)
Lactobacillus rhamnosus GG re-shapes gut microbiota and triggers STING-type I IFN-dependent antitumor immunity (2022) (0)
Principles of Endocrine Therapy (2000) (0)
Histological and in vivo characterization of oligo- and poly- metastasis(es) derived from tail-vein injected MDA-MB-435-GFP lung derivative cell lines. (2011) (0)
Dynamic-Contrast-Enhanced-MRI shows radiation resistant tumor (Nu61) is also resistant to TNFalpha treatment – pilot study (2009) (0)
Reply to H.W. Daniell and to L. Azoulay and S. Suissa (2010) (0)
Chapter 3 – Principles and Applications of Radiation Oncology (2005) (0)
Patients with Relapsed or Refractory- Hodgkin's Disease (1991) (0)
Characterization of Response to Radiation Mediated Gene Therapy via MultiModality Imaging (2009) (0)
Characterization of 3 cell lines derived from a squamous cell carcinoma (1991) (0)
In Reply to Zaghloul. (2016) (0)
Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis (2018) (0)
TITLE: Human Organoids Share Structural and Genetic Features with Primary Pancreatic Adenocarcinoma Tumors AUTHOR AND AFFILIATIONS: (2018) (0)
The Radiation Oncologist (2003) (0)
Regulation of gene expression by ionizing radiation (1991) (0)
Section 27: The Thorax (2003) (0)
A High Throughput Cell-based Screen Identifies Compounds That Inhibit the Viral Oncoprotein E6 in Human Papillomavirus-positive Cancers (2012) (0)
P14.27 Pathogenic Genomic Alterations of CDKN2A Predict Immunotherapy Resistance in NSCLC (2021) (0)
Rab31 upregulates MUC1-C expression. (2012) (0)
Activation of signal transduction pathways by ionizing radiation Applications to radiation-induced gene therapy (1994) (0)
In response to Drs. Hanks and Lee (1996) (0)
Concomitant I nfusional P aclitaxel a nd F luorouracil, O ral Hydroxyurea, a nd H yperfractionate d R adiation f or L ocally Advanced S quamous H ead a nd N eck C ancer (2001) (0)
Prospective Assessment of Radiation Dose Toxicity Correlations in Patients Who Received Intensity Modulated Total Marrow Irradiation (IM-TMI) as Part of Conditioning Regimen Prior to Stem Cell Transplant (2016) (0)
Section 16: Bone Marrow Transplantation (2003) (0)
Radiation Assisted Viral Oncolytic Therapy (RaVOLT): IR Activates HSV-1 Viral Promoters to Enhance Viral Replication and Tumor Eradication (2005) (0)
Predefinitive and postdefinitive chemotherapy for locally advanced squamous carcinoma of the head and neck. (1979) (0)
Part III Cancer Diagnosis (2003) (0)
Part VI Cancer Management (2003) (0)
Use of novel radiosensitizers and radiation-specific miRNAs to modulate radiation response in non-small cell lung adenocarcinoma (NSCLC). (2010) (0)
Comprar Nanotechnology Applications in Radiology and Radiation Oncology | Ralph R. Weichselbaum | 9781420076561 | Informa Healthcare (2008) (0)
Mice lackingserum paraoxonasearesusceptible toorganophosphate toxicityandatherosclerosis (1998) (0)
Hypofractionated Image Guided Radiotherapy for Large Volume Oligometastases (2010) (0)
Advances in Brief Footprinting of Individual Tlimors and Their Variants by Constitutive Cytokine Expression Patterns 1 (2006) (0)
Protein kinase C participation in the cellular response to ionizing radiation (1991) (0)
INDUCTION OF APOPTOSS BY CELLULAR STRESS CROSS REFERENCE TO RELATED APPLICATIONS (2017) (0)
Abstract LB-162: DNA-damage foci persistence and accelerated senescence as determinants of radiosensitization by glycolysis inhibitors (2011) (0)
Staging and treatment of Hodgkin's disease. (1979) (0)
Length of follow-up influences biochemical control rates after treatment for prostate cancer (1999) (0)
Radiobiological analysis of human tumors from patients with known clinical outcome (1989) (0)
Expedition Inspiration Fund for Breast Cancer Research Meeting 2003 (2003) (0)
2703: H2a.x Phosphorylation Is Differentially Expressed in Adult Mice Tissues and Tumor Regions Following Whole Body Radiotherapy in a Dose Dependent Manner (2006) (0)
Overall survival according to immunotherapy and radiation treatment for metastatic non-small-cell lung cancer: a National Cancer Database analysis (2019) (0)
Possible involvement of chromosome 7 in human squamous cell carcinoma (1987) (0)
TNF Signaling and SOD2 in Adaptive Responses (2012) (0)
Investigation of the essential role of platelet-tumor cell interactions in metastasis progression using an agent-based model (2014) (0)
Preferences of patients and the fallacy of the five-year survival. (1979) (0)
The interaction between human recombinant tumor necrosis factor — alpha and radiation in human carcinoma and sarcoma cell lines (1989) (0)
Three dimensional dose modelling of alpha and beta particle emitters for intraperitoneal radioimmunotherapy (1989) (0)
Section 10: Medical Oncology (2003) (0)
Long-term clinical outcomes and transcriptional analysis following partial and complete tumor SBRT plus pembrolizumab. (2019) (0)
Cisplatin, 5-Fluorouracil and high dose oral Leucovorin (PFL) with Methotrexate and Piritrexim as Neo-Adjuvant chemotherapy for head and neck cancer (1991) (0)
Genetically engineered herpes viruses for the treatment of tumors (2000) (0)
Systemic delivery by intravenous injection of gamma-1-34.5-deleted HSV-1 for oncolytic viral therapy (2007) (0)
154 Radiation targeted TNF gene therapy in TNF-resistant prostate cancer (1997) (0)
Response to laramore (1990) (0)
Preclinical Model to Predict Anti-Leukemic Activity of Busulfan and Irradiation (2012) (0)
Methotrexate penetration of human osteogenic sarcoma multitumor cell spheroids: an in vitro model for micrometastases and adjuvant chemotherapy (1979) (0)
The Response of Human Cells to In Vivo Methylation Damage (1989) (0)
2017 Significance of timing of adjuvant radiotherapy in patients with cerebral meningioma (1996) (0)
Salvage RT for Biochemical Failure Post-prostatectomy: Do We Reduce or Increase Toxicity of Treatment With IMRT? (2007) (0)
Section 32: The Skin (2003) (0)
Comprar Nanotechnology Applications in Radiology and Radiation Oncology | Gayle E. Woloschak | 9781420076578 | Informa Healthcare (2008) (0)
p52 signaling promotes cellular senescence (2022) (0)
Section 13: Biotherapeutics (2003) (0)
Pancreatic adenocarcinoma human organoids share structural and genetic features with primary tumors (2018) (0)
Abstract 5019: Irradiation and anti-B7-H1 provide synergistic treatment effects in murine cancer (2014) (0)
Recovery from fractionated radiation in plateau phase human melanoma cells (1981) (0)
p52 signaling promotes cellular senescence (2022) (0)
Hypofractionated Image-guided Radiation Therapy in the Treatment of Oligometastatic Renal Cell Carcinoma (2010) (0)
Abstract IA-028: Interaction of radiotherapy and immunotherapy: Maybe not what you think (2021) (0)
Drug–Radiotherapy Combination Trial Developments—Response (2021) (0)
Low Recombination Proficiency Score (RPS) in Breast Cancer Predicts Malignant Potential and Heightened Sensitivity to DNA-damaging Therapies (2015) (0)
Figure 34.14, [Data points represent volume changes...]. (2000) (0)
Irradiation-Induced Dynamics of Signaling Sphingolipids in Mice. (2009) (0)
A 11 Patent Number : 5 , 641 , 755 45 Date of Patent : Jun . 24 , 1997 (2017) (0)
Abstract 1874: First demonstration that hypoxia targeting with radiation improves tumor control in a mammal tumor model (2017) (0)
Section 20: Multidisciplinary Management (2003) (0)
Low-dose X-ray radiotherapy–radiodynamic therapy via nanoscale metal–organic frameworks enhances checkpoint blockade immunotherapy (2018) (0)
Estimates of dose to intraperitoneal micrometastases from alpha and beta emitters in radioimmunotherapy (1991) (0)
GADD45a Is A Viable Target In Radiation-induced Murine Lung Injury (2010) (0)
The genetic basis of delayed tumor necrosis factor-alpha (TNFα) - mediated tumor cell death (2006) (0)
PL 11 Applications of gene/viral therapy in combination with radiation therapy (1997) (0)
Dose Escalated Radiation Therapy for High Risk Prostate Cancer: Outcomes in the Modern Era with Shor (2009) (0)
Human Papillomavirus Expression and p53 Accumulation in Squamous Cell Carcinoma of the Oral Cavity and Tonsil (1995) (0)
COMBINATION WITH TYROSINE KNASE INHIBITORS (2017) (0)
Part II Scientific Foundation (2003) (0)
Burden during Radiation Therapy Prolonged Treatment with Angiostatin Reduces Metastatic (2003) (0)
Protein kinase C mediates x-ray inducibility of nuclear signal transducers EGR 1 and JUN ( protein kinase inhibitors / immediate early genes / radiation injury (0)
Involvement of c-Abl Tyrosine Kinase in Apoptotic Response to Anticancer Agents (1999) (0)
Comprar Holland Frei Cancer Medicine Review | Emil Frei, III | 9781550093094 | BC Decker (2007) (0)
Molecular Classification of Lymph Node Metastases in HPV-Negative Head and Neck Cancers Identify Distinct Phenotypes That Predict for Survival (2018) (0)
Host stroma determines the tumor response to radio-inducible TNF-alpha based gene therapy (2006) (0)
Section 2: Cancer Immunology (2003) (0)
The Impact of Race and Mammographic Detection in Early Breast Cancer (2007) (0)
Section 8: Surgical Oncology (2003) (0)
Alteration of cell cycle parameters by 17 beta estradiol (17 be) in a human breast carcinoma line In vitro: implications for combination therapy in vivo (1978) (0)
The role of radiation therapy in soft tissue sarcomas of childhood (1977) (0)
Abstract 3043: Survivin-mediated radio-sensitization response in p53 mutant tumor cells (2016) (0)
Inhibition of NF-κB activity by Temozolomide involves O6-methylguanine induced reduction of p65 DNA-binding. (2007) (0)
Rhythmic radiotherapy beats down TGF-β (2017) (0)
Long-Term Toxicities Using Intensity Modulated Total Marrow Irradiation as a Conditioning Regimen for Advanced Hematologic Malignancies (2017) (0)
Identifying Constraints on a Set of Putative Mechanisms Affecting the Dynamics of Oligo- Versus Poly-metastases Using Agent-based Modeling (2013) (0)
Section 24: The Eye (2003) (0)
Type 3 innate lymphoid cell-derived lymphotoxin prevents microbiota-dependent inflammation (2017) (0)
Advances in Brief Replication-competent , Nonneuroinvasive Genetically Engineered Herpes Virus Is Highly Effective in the Treatment of Therapy-resistant Experimental Human Tumors 1 (2000) (0)
Oligometastases: Characterizing the Role of Epigenetic Regulation of Epithelial-Mesenchymal Transition. (2023) (0)
Dual Blockade of CD47 and HER2 Re-sensitizes Resistant Breast Cancer Cells to Radiation Therapy (2019) (0)
Ionizing Radiation-Mediated Protein Kinase C Activation and Gene Expression (1991) (0)
Contents, Vol. 28, 1989 (1982) (0)
Prognostic factors in asymptomatic hodgkin's disease, stages IA–IIIA (1980) (0)
P05 06 SP – PROTEIN KINASE C ACTIVATION BY X-RAYS MEDIATES EXPRESSION OF TUMOR NECROSIS FACTOR (1991) (0)
Section 7: Imaging (2003) (0)
The Primary Physician (2003) (0)
Oncology 1: Basic ScienceCharacterization of Early Events for Potential Metastases Adhesion and Survival Using an Agent-Based Model: Examination of Potential Differential Effects of Anti-Platelet Therapies (2014) (0)
Genetically modified herpes virus for the treatment of cardiac and vascular diseases (2001) (0)
Effect of 17 beta estradiol (17BE) on the repair of potentially lethal X-ray damage in human breast cancer cell (1980) (0)
Kinase C following Activation by Ionizing Radiation Tumor Necrosis Factor Gene Expression Is Mediated by Protein Updated (2006) (0)
Identification of a novel MEK signaling pathway that determines tumor selective replication of herpes simplex type-1 (HSV-1) viruses in pancreatic cancer (2005) (0)
Induction chemotherapy followed by concurrent chemoradiation for advanced head and neck cancer: improved disease control and survival in Classic Papers and Current Comments, Head and Neck Cancer Research (1999) (0)
Ionizing Radiation-Mediated Protein Kinase C Activation and Gene Expression (1991) (0)
Intraperitoneal administration of a mutant herpes simplex virus (HSV) achieves systemic cytotoxicity in tumors that overexpress MEK: A novel oncolytic strategy (2006) (0)
Abstract 1369: Mouse models of clinical oligo- and poly-metastatic progression (2012) (0)
DDX39B interacts with the pattern recognition receptor pathway to inhibit NF-κB and sensitize to alkylating chemotherapy (2020) (0)
Increased Susceptibility of GADD45α Null Mice in a Model of Radiation-Induced Lung Injury (RILI). (2009) (0)
Abstract 2773: Increased tumor control boosting hypoxic regions identified with EPR pO2 imaging in 2 tumor types (2020) (0)
Section 28: Gastrointestinal Tract (2003) (0)
Abstract PL2: The role of radiotherapy combined with immunotherapy in oligometastatic cancer (2020) (0)
2021 : Long Term Outcome for Early Breast Carcinoma: The University of Chicago Multi-Center Experience (2006) (0)
2021 Enhanced replication of attenuated HSV-1 in irradiated human glioma xenografts (1997) (0)
Toxicity of chemotherapy and radiotherapy in the treatment of locally advanced cancer of the head and neck (1984) (0)
Effects of race and insurance status on serum prostate specific antigen (PSA) levels in localized prostate cancer patients (1994) (0)
Abstract 2253: Lymphangiogenesis augments the anti-tumor efficacy of radiotherapy in mouse melanoma (2020) (0)
Racial disparities in early breast cancer outcomes in a mammographic screened population (2007) (0)
Abstract 4759: TP53 control of the survivin-mediated radio-adaptive response in human tumors (2017) (0)
The Psycho-oncologist (2003) (0)
315: DEVELOPMENT OF POSTOPERATIVE LOCAL TUMORS AND DISTANT METASTASES IS DIET, GENETICS, AND MICROBIOME-DEPENDENT IN A MOUSE MODEL OF COLORECTAL CANCER RECURRENCE (2022) (0)
Radiation-Induced Equilibrium Is a Balance (2013) (0)
The natural chemopreventive anti-ageing compound resveratrol induces the tumor suppressor Egr1 through a complex genetic network (2006) (0)
In Vitro and in Vivo Activity of Protein Kinase C Inhibitor Chelerythrine Chloride Induces Tumor Cell Toxicity and Growth Delay in Vivo 1 (2000) (0)
S05 05 SA – EVALUATION OF DIFFERENT IN VITRO ASSAYS OF INHERENT SENSITIVITY AS PREDICTORS OF RADIOTHERAPY RESPONSE (1991) (0)
PS04.08 A Phase I Trial to Evaluate Concurrent or Sequential Ipilimumab, Nivolumab, and Stereotactic Body Radiotherapy in Stage IV NSCLC: Topic: Medical Oncology (2017) (0)
Chromosomal instability mediates immune exclusion and response to cytotoxic chemotherapy in colorectal liver metastases (2021) (0)
Abstract LB-178: In vivo validation of candidate radiosensitizers that target ionizing radiation induced foci (2014) (0)
Protochemotherapy for stage IIIB non-small cell lung cancer (1989) (0)
Efficacy of concomitant chemoradiotherapy in poor prognosis head and neck cancer (1991) (0)
Induction of Inflammatory Macrophages in Solid Tumors by All-trans Retinoic Acid Augments Radiation Efficacy (2022) (0)
Glioblastoma by Temozolomide in Experimental α Necrosis Factor Transcriptional Targeting of Adenovirally Delivered Tumor (2004) (0)
Association of LDL Levels with Biochemical Failure after Radiotherapy for Prostate Cancer (2009) (0)
Section 37: Pediatric Oncology (2003) (0)
Curative radiotherapy following chemotherapy for bladder carcinoma (1989) (0)
2117 Organ preservation in stage II and III head and neck cancer utilizing alternate week concomitant chemoradiotherapy (1996) (0)
Protein kinase C mediates x-ray inducibility of nuclear signal (2016) (0)
Immunotherapy with Ad-LIGHT enhances radiation induced tumor cell death (2007) (0)
Section 29: Genitourinary Tract (2003) (0)
EP-1316: Clinical experience with intensity modulated radiation total marrow irradiation (IMTMI) (2013) (0)
135 Genetic radiotherapy using an adenoviral vector inhibits tumor growth by direct and indirect mechanisms of tumor cell killing (1996) (0)
Statin Therapy for Prostate Cancer: Understudied and Underutilized (2011) (0)
Surgical Approach to Organ Preservation in the Treatment of Cancer of the Larynx (2017) (0)
Tumor Necrosis Factor Gene Expression Is Mediated by Protein Kinase C following Activation by Ionizing Radiation 1 (2006) (0)
Measuring γ-H2AX Induction after Ionizing Radiation (IR) and Drug Therapy using a Streamlined Flow Cytometry Assay (2005) (0)
Subject Index Vol. 17, 1994 (1994) (0)
2042 A novel therapeutic approach for hepatocellular carcinoma using replication-competent herpes simplex virus and ionizing radiation (1999) (0)
Author Correction: Synergistic checkpoint-blockade and radiotherapy–radiodynamic therapy via an immunomodulatory nanoscale metal–organic framework (2022) (0)
101 Impotence prevalence follow ing external beam radiation therapy for localized prostate cancer (1995) (0)
Radiosensitization in Viral Gene Therapy (2008) (0)
Section 35: Neoplasms in Aids (2003) (0)
Section 40: Oncologic Emergencies (2003) (0)
640 Stat1 as mediator of acquired tumor radioresistance and potential target for anti-tumor therapy (2004) (0)
Stereotactic Radiotherapy for Pulmonary (2014) (0)
Advances in Brief Defective Induction of Stress-activated Protein Kinase Activity in Ataxia-Telangiectasia Cells Exposed to Ionizing Radiation 1 (2006) (0)
A phase 1/2A trial of synthetic DNA vaccine immunotherapy targeting HPV-16 and -18 after chemoradiation for cervical cancer. (2018) (0)
Inhibition Of Sphingolipid De Novo Biosynthesis Ameliorates Radiation-Induced Lung Inflammation And Fibrosis (2012) (0)
A Genomic Screening Based Strategy for the Creation of Radiation Inducible Gene Therapy Vectors (2008) (0)
Neoplasms of the Eye (2000) (0)
Chromatin signaling in DNA damage checkpoint response (2008) (0)
Radiosensitization by Gene Therapy (2005) (0)
Section 15: Gene Therapy (2003) (0)
143 Race and clinical outcome in breast cancer: A 40-year follow-up (1995) (0)
Myeloablative Fludarabine/ IV Busulfan Combined With Linac Based Intentsity Modulated Total Marrow Irradiation (IM-TMI) In Allogeneic Stem Cell Transplant For High Risk Hematologic Malignancies: A Phase I Study (2013) (0)
2004 Influence of race on outcome in patients treated with breast conserving therapy (1995) (0)
Prognostic significance of stage, grade, race, pre-treatment PBX, PBX half-life, prostate volume and PBX density in patients undergoing external beam radiotherapy for localized prostate cancer: A logistic regression analysis (1993) (0)
Retuning the Radio in Radiobiology. (2018) (0)
Randomized Phase II Study of Paclitaxel ( 1-Hour Infusion ) , Fluorouracil , Hydroxyurea , and Concomitant Twice Daily Radiation with or without Erythropoietin for Advanced Head and Neck Cancer (2003) (0)
Vascular targeting of Ad.Erg-TNF and IR elevates serum angiostatin levels (1998) (0)
Part IX Informatics (2003) (0)
Analysis of Tumor-Initiating Cells in Engrafted Patient-Derived Human Bladder Carcinomas May Direct Precise Cancer Therapy (2014) (0)
Abstract 3659: NF-κB1-p50 is a novel mediator of methylation-induced apoptosis (2010) (0)
Abstract B93: Tumor lymphangiogenesis improves responsiveness to radiotherapy in mouse melanoma (2020) (0)
4-Hydroxyacetophenone Modulates the Cytoskeleton through Nonmuscle Myosin-2C to Reduce Metastasis (2019) (0)
Section 14: Endocrine Therapy (2003) (0)
Abstract 4157: Second tumor type showing hypoxia targeting with radiation improves tumor control in a mammal tumor model (2018) (0)
Optimization of parameters in radioimmunotherapy (1990) (0)
P13 13 MP – DIFFERENTIAL SIGNAL TRANSDUCTION PATHWAYS MEDIATE X-RAY-INDUCED TRANSCRIPTION FACTOR EXPRESSION (1991) (0)
Advance SBRT approaches for patients with oligometastases (2019) (0)
Section 4: Cancer Epidemiology, Prevention, and Screening (2003) (0)
Section 33: Bone And Soft Tissue (2003) (0)
Part I Cardinal Manifestations (2003) (0)
Author Correction: Tumor aneuploidy predicts survival following immunotherapy across multiple cancers (2023) (0)
153 The tumor vasculature is a target for genetic radiotherapy (1997) (0)
Abstract 573: Ionizing radiation activates IFN signaling in tumor cells (2011) (0)
Abstract 507: Elevated manganese superoxide dismutase (SOD2) activity as a mechanism for the low dose dadiation- and thiol-induced adaptive responses in human RKO36 colon carcinoma cells and BFS2C mouse fibrosarcoma cells (2010) (0)
Section 12: Chemotherapeutic Agents (2003) (0)
Total Marrow Irradiation Combined with High-Dose Melphalan for Patients with Relapsed/Refractory Multiple Myeloma: A Phase 1 Study (2017) (0)
Sachwortregister Band 17, 1994 (1994) (0)
Gynecologic Oncologist (2003) (0)
Conservative surgery and adjuvant irradiation in the management of adult soft tissue sarcoma: Clinical and radiobiological results (1993) (0)
Section 17: Psycho-Oncology (2003) (0)
Activated MEK Suppresses Activation of PKR and Enables Efﬁcient Replication and In Vivo Oncolysis by (cid:2)(cid:3) 1 34.5 Mutants of Herpes Simplex Virus 1 (2006) (0)
MUCing around with tumor suppression (2008) (0)
Abstract 1546: Effective co-targeting of tumor and tumor stroma for head and neck cancer treatment: making the right combination (2010) (0)
Section 25: Endocrine Glands (2003) (0)
Abstract 196: Effects of an Engineered Herpes Simplex Virus (HSV-1) on Vascular Cell Adhesion (2013) (0)
Part VIII Complications (2003) (0)
Theory and Practice of Clinical Trials (2000) (0)
Induction of EGR-TNF Radioinducible virus through BH3 Domain Antagonism with Chelerythrine Chloride (2009) (0)
Section 22: Societal Oncology (2003) (0)
Panel discussion continued. the role of chemotherapy in treatment of advanced squamous cell cancer of the head and neck (1984) (0)
Physical Basis of Radiation Therapy (2003) (0)
Radiation and Angiostatin Target the Tumor Vasculature: A New Paradigm for Prostate Cancer Treatment (1999) (0)
Section 11: Chemotherapy (2003) (0)
Dimethylaminomicheliolide Sensitizes Cancer Cells to Radiotherapy for Synergistic Combination with Immune Checkpoint Blockade (2021) (0)
Low frequency ESR spectrometry: Application in biological systems (1987) (0)
United States Patent Weichselbaum (2017) (0)
Section 30: Female Reproductive Organs (2003) (0)
217: Host and Tumor Immunity: Local and Systemic Opportunities to Enhance Tumor Curability by Radiotherapy (2014) (0)
061. Surfactant Induced Sealing of Radiopermeabilized Mammalian Cell Membranes (1995) (0)
MODULATING RAD51 AND HOMOLOGOUS RECOMBINATION (2017) (0)
Evaluation of Initial Metastatic Tumor Location and Radiation Response to Determine Outcomes in Patients Who Received Combination Stereotactic Body Radiotherapy and Immunotherapy for NSCLC. (2021) (0)
1 Cardinal manifestations of cancer (2016) (0)
2137 Clinical and biochemical outcome following conformal radiotherapy for prostate cancer: A focus on racial differences (1999) (0)
Section 6: Cancer Pathology (2003) (0)
Receptor-mediated cytotoxicity of iodine-125 labeled hormones (1982) (0)
Factors Associated with Non-cancer Mortality in Advanced Head and Neck Cancer: A Competing Risks Analysis (2008) (0)
Tumor Cells Regulates Both Cytotoxic and Prosurvival Functions in Signal Transducer and Activator of Transcription 1 (2007) (0)
Section 38: Complications of Cancer and its Treatment (2003) (0)
Rhabdomyosarcoma (1982) (0)
Attenuated herpes simplex virus blocks neointimal hyperplasia induced by balloon injury and low shear stress in a dose-dependent fashion (2009) (0)
X-Ray and m-Dianiminedichloroplatinum ( II ) Cross-Resistance in Human Tumor Cell Lines 1 (2006) (0)
14q32-Encoded MicroRNAs Mediate Oligometastasis (2015) (0)
Abstract 67: A novel survivin-mediated adaptive response induced by very low dose imaging-level exposures and radiation therapy. (2013) (0)
Part V Multidisciplinary Management (2003) (0)
Involvement Of Acute Lung Injury Genes In Murine Radiation-induced Lung Injury (RILI) (2010) (0)
A molecular model for the study of accelerated repopulation (1994) (0)
Effects of dexamethasone and cortisone with x-ray irradiation on transformation of C3H 10T 1/2 cells. (1981) (0)
Protein Kinase C-dependent Signaling Pathway Human Myeloid Leukemia Cells : Potential Involvement of a Expression in jun-Diamminedichloroplatinum ( II ) Induces ccis Updated (2006) (0)
Author Correction: Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis (2018) (0)
O6-methylguanine DNA Damage Signals Through Nfkb1/p50 to Potentiate DNA Strand Break-induced Cytotoxicity (2012) (0)
A Phase 1 Study of Total Marrow Irradiation Combined with High-Dose Melphalan for Patients with Relapsed/ Refractory Multiple Myeloma (2016) (0)
Part IV Therapeutic Modalities (2003) (0)
Tumor-promoting stroma impregnated by cancer cells is destroyed by specific T cells (2008) (0)
ASO Visual Abstract: Phase II Prospective Open-Label Randomized Controlled Trial Comparing Standard of Care Chemotherapy with and without Sequential Cytoreductive Interventions for Patients with Oligometastatic Foregut Adenocarcinoma and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid (ctDNA (2022) (0)
A novel paradigm in the treatment of solid tumors with TNF{alpha}: TNFerade biologic (AdGVEGR.TNF.11D) gene therapy approach to drug delivery. (2010) (0)
Proliferation Kinetics of a Human Breast Cancer Line in Vitro following Treatment with 17/3-E stradici and 1-ÃŸ-D-Arabinofuranosylcytosine1 (2006) (0)
Methotrexate penetration of human osteo sarcoma spheroids a proposed model for solid tumor resistance to adjuvant chemo therapy (1980) (0)
Evaluation of a prototype treatment planning system (TPS) designed for biology-guided radiotherapy for SBRT of oligmetastases (2019) (0)
Principles of Radiation Therapy (1986) (0)
507 Evaluation of patients with progressive metastatic head and neck cancer treated with PD-1 inhibition with Pembrolizumab and radiation therapy: Assessment of local and systemic effects (2015) (0)
Dual Induction of the Epo-Egr-TNF-α Plasmid in Hypoxic Human Colon Adenocarcinoma Produces Tumor Growth Delay (2003) (0)
Beyond the Visible Spectrum: Considering the Oligometastatic Hypothesis in the Light of a New Era. (2022) (0)
VIRUS HSV PRESENTANT UNE CARENCE EN Ϝ134.5 ET VOIE MAPK (2007) (0)
Translational Research in Acute Lung Injury and Pulmonary Fibrosis Role of GADD 45 a in murine models of radiation-and bleomycin-induced lung injury (2015) (0)
Towards a molecular basis of oligometastatic disease: potential role of micro-RNAs (2014) (0)
Section 26: Head and Neck (2003) (0)
Hypofractionated radiotherapy for oligometastatic non-small cell lung carcinoma. (2010) (0)
Immunoradiotherapy goes club(bing) (2021) (0)
Increasing the Therapeutic Ratio of Oncolysis by Optimally Integrating Radiotherapy into the Replicative Cycle of Oncolytic HSV-1 for High Grade Gliomas (2009) (0)
Nanoscale metal-organic frameworks enhance radiotherapy to potentiate checkpoint blockade immunotherapy (2018) (0)
Brief Concomitant Exposures to Angiostatin Potentiation of the Antitumor Effect of Ionizing Radiation by Updated (2006) (0)
Abstract 861: Survivin-mediated adaptive response: a risk factor for IGRT (2014) (0)
erratum: p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage (1999) (0)
Does the retinoblastoma gene play a role in the initiation of sarcomas (1989) (0)
Racial Parities in Outcomes After Radiation Therapy for Head-and-Neck Cancer (2013) (0)
LINAC-based intensity modulated total marrow irradiation (TMI) in addition to myeloablative fludarabine/IV busulfan conditioning prior to allogeneic stem cell transplant for high-risk hematologic malignancies: A phase I study. (2014) (0)
Intensive induction chemotherapy followed by concomitant chemoradiotherapy in the management of locoregionally advanced carcinoma of the pyriform sinus. (2003) (0)
Evidence for the Use of Multiple Mechanisms by Herpes Simplex Virus-1 R7020 to Inhibit Intimal Hyperplasia (2015) (0)
Immunostimulatory nanomedicines synergize with checkpoint blockade immunotherapy to eradicate colorectal tumors (2019) (0)
E-102 Destruction of the tumor microenvironment by neoantigen-specific T cells prevents relapse of therapy-resistant cancer variants (2019) (0)
In vitro radiosensitivity of fibroblasts from patients with familial and sporadic retinoblastoma: A naturally occurring model for the study of mutagenesis and carcinogenesis (1978) (0)
The Pediatric Oncologist (2003) (0)
Suppression of local IFN-I by commensal microbiota-derived butyrate impairs antitumor effects of ionizing radiation (2022) (0)
Section 41: Oncology and Informatics (2003) (0)
Section 5: Clinical Trials and Outcomes Assessment (2003) (0)
Section 9: Radiation Oncology (2003) (0)
Principles of Multidisciplinary Management (2003) (0)
All-Trans Retinoic Acid Radiosensitizes Neuroendocrine Tumor Cells via Peptidyl-Prolyl Cis-Trans Isomerase 1 Inhibition (2023) (0)
Non-Muscle Myosin Light Chain Kinase Promotes The Development Of Non-Small-Cell Lung Cancer (2010) (0)
Abstract LB-251: Radiotherapy sensitizes pancreatic cancer to immunotherapy by promoting T cell infiltration (2016) (0)
Inhibition of Estrogen Receptor Alpha Radiosensitizes Neuroendocrine Tumors (2023) (0)
Abstract 1436: TNF-alpha-dependent tumor reprogramming and promotion by microenvironment: Potential involvement of endothelial cells. (2013) (0)
Radiotherapy failure is associated with inherent cellular radioresistance (1987) (0)
Abstract 2746: An evaluation of poly (ADP-ribose) polymerase inhibitor efficacy in head and neck cancer (2014) (0)
Overall Survival According to Systemic and Radiation Treatment Approaches in Metastatic Non-Small-Cell Lung Cancer: A National Cancer Database Analysis (2019) (0)
GENE INDUCTION BY IONIZING RADIATION (1992) (0)
ePoster SessionsPredicting for Long-Term Survival in Oligometastatic Patients Treated With Ablative Radiation Therapy: A Multi-institutional Pooled Analysis (2017) (0)
The effect of subcutaneous (SC) recombinant human erythropoietin (EPO) in cancer (Ca) patients (pts) receiving radiotherapy (RT) (1992) (0)
Chemical Modulation of the Hypoxic Fraction in the Treatment of Head and Neck Cancer (1982) (0)
2161 Reduction of adverse effects of combined modality therapy with subtotal nodal irradiation in stage IIIA Hodgkin's disease (1996) (0)
Section 19: Cancer Rehabilitation Medicine (2003) (0)
Correlation of homologous recombination deficiency in head and neck cancer with sensitivity to PARP inhibition. (2014) (0)
Treatment Planning and Delivery (2003) (0)
Integrated Molecular Subtyping of Clinical Metastasis: Implications for Defining a Curable Oligometastatic State (2018) (0)
1033 Efficacy of preoperative concurrent 5-FU and mitomycin-C with radiation therapy for locally advanced rectal cancer (1996) (0)
64 evaluation of a gene therapy system using a replication competent, non-neurovirulent HSV-1 viral vector used tn combination with radiotherapy (1995) (0)
QS358. Programmed Cell Death in Low Shear Stress and Balloon Induced Arterial Restenosis (2008) (0)
Part VII Pediatric Oncology (2003) (0)
Section 18: Oncology Nursing (2003) (0)
X-Ray and m-Dianiminedichloroplatinum(II) Cross-Resistance in Human Tumor Cell Lines1 (2006) (0)
Protein Kinase C Inhibition Induces Apoptosis and Ceramide Production through Activation of a Neutral Sphingomyelinase 1 (2006) (0)
Retraction. Blockage of the early events of mitogenic signaling by interferon-gamma in macrophages in response to colony-stimulating factor-1. (1996) (0)
A proliferative subtype of colorectal liver metastases exhibits hypersensitivity to cytotoxic chemotherapy (2022) (0)
RIG-1-Like Receptor LGP2 Protects Tumor Cells From Ionizing Radiation (2014) (0)
The use of concomitant radiotherapy and an attenuated herpes simplex-1 virus improves survival, in intracranial glioblastoma multiforme tumors (astro research fellowship) (1998) (0)
Host STING-dependent MDSC mobilization drives extrinsic radiation resistance (2017) (0)

This paper list is powered by the following services:

Other Resources About Ralph Weichselbaum

en.wikipedia.org

What Schools Are Affiliated With Ralph Weichselbaum?

Ralph Weichselbaum is affiliated with the following schools:

Ralph Weichselbaum's Academic­Influence.com Rankings